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Introduction 
 
Sexual differentiation is the process through which individuals develop sexual characters 
and show masculine or feminine pattern of sexual behaviour. Most vertebrate species 
have two sexes, males and females which are defined by their ability to produce sperm or 
eggs, respectively. The sex chromosomes are the origin of all sex differences in a lot of 
animal species. In mammals, males have an X and a Y chromosome while females have 
two X chromosomes. The most important genetic difference occurs in a particular gene 
expressed only in the Y chromosome. This critical gene is SRY, which is necessary for 
differentiation of testes from the bipontential gonad (Koopman et al. 1991). The SRY 
gene encodes the transcription factor known as the testis-determining factor which 
upregulates the expression of other genes that induce testicular differentiation and 
development (Kashimada and Koopman 2010). In the absence of SRY, the gonad will 
develop into an ovary. In rodents, the development of testes in males and ovaries in 
females leads to sex differences in the perinatal secretion of testosterone, which induces 
differentiation of the genitalia and the brain. In fact, testosterone, released by fetal testes,  
enters the male brain, where it is converted to estradiol by the P450scc enzyme 
aromatase. Estradiol acts on estrogen receptors to cause masculine differentiation of 
several brain regions, inducing the formation of circuits that are required for masculine 
behaviours, including mating (mounting, intromission and ejaculation), aggression, 
territorial marking, and parental care (McCarthy 2008; Wu et al. 2009). 
In particular, estradiol permanently alters the reproductive physiology by preventing its 
positive feedback effects on gonadotropin luteinizing hormone (LH) production and 
release from the pituitary in adulthood. By contrast, in females a lack of early exposure to 
high levels of estradiol is essential for the ovulatory surge of LH and for the development 
of sexual behaviour (Barraclough 1961). High levels of estradiol in maternal circulation 
could also access the fetal circulation, but perinatal fetuses and pups are protected by 
maternal estradiol because they carry the -fetoprotein (Afp), which binds estrongens. 
Afp does not bind testosterone, so this hormone can selectively enter into the neurons, 
where it is aromatized to estradiol. The importance of -fetoprotein in protecting female 
fetuses from behavioural masculinization and fertility has been established in Afp mutant 
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mice (Afp
−/−
). In fact, female offspring of Afp
−/−
 dams were incapable of -fetoprotein 
production, and their brain was defiminized behaviourally and morphologically (Bakker 
et al. 2006).  
Brain sexual differentiation is therefore largely controlled by steroids produced by the 
gonads that act on the brain during a perinatal sensitive period to organize a male or 
female phenotype. This sensitive period for steroid-induced sexual differentiation is 
defined by the onset of testicular androgen secretion in males (approximately embryonic 
day 18 in rodents) and by the loss of sensitivity of the female to exogenous androgen 
treatment (approximately postnatal day 10) (Figure 1). 
Subsequent to this differentiation, the same gonadal hormones act on the male or female 
brain across the lifespan to produce sex-specific behaviours. This evidence leads to the 
concept of organizational and activational effects of gonadal steroids on the brain. 
Organizational effects are the permanent effects induced by gonadal steroids, during a 
critical perinatal period of fetal and neonatal life in mammals, which permanently alters 
the neural architecture of the brain. In contrast, activational effects are transient effects 
seen following steroids exposure in adulthood (Phoenix et al. 1959). 
 
Cellular mechanisms of Estradiol mediated sexual differentiation of the brain 
Sexual differentiation of the brain and sex behaviour involves three distinct processes: 
feminization, masculinization and defeminization. Masculinization and defeminization 
are distinct processes in the male brain, both of which rely on gonadal hormone action 
during the perinatal period. Masculinization is the process through which the brain 
becomes capable of producing male sexual behaviour in adulthood. Defeminization is the 
process whereby the ability to express female sexual behaviour or productive function is 
lost. Feminization is a default program that proceeds in the absence of organizing steroid 
hormone action and that organizes the brain regions controlling female sexual behaviour, 
so that the behaviours such as lordosis can be displayed under the proper hormonal 
conditions in adulthood (for a review see Lenz et al. 2012). 
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Figure 1. The organizational/activational hypothesis of estradiol action on the developing brain. 
Exposure of developing females to androgens during the period of sexual differentiation, which in 
rats begins around embryonic day 18 and extends up to 10 days postnatally, results in their 
aromatization to estradiol and masculinization of adult brain and behaviour. Estradiol induces a 
malfunction of the female neuroendocrine axis in adulthood, rendering females sterile and 
sexually unreceptive. In fact, females do not adopt the sexually receptive posture termed lordosis 
(from McCarthy 2008). 
 
 
Neuronal sex differences occur on a variety of levels, including differences in the volume 
of certain brain nuclei, or difference in dendritic spine density, neurite branching, 
particular projection from one brain area to another or astrocyte complexity (Gorski et al. 
1978; Mong et al. 2001). In the rodent, many of these sex differences are determined by 
steroid hormones, particularly estradiol, and are established by diverse downstream 
effects. Once aromatized from testosterone, estradiol acts in the brain on several different 
estrogen receptors (ERs): ER, once thought to be the only estrogen receptor, the more 
recently characterized ER, and the G-protein-coupled receptors ER-X and GPR30. The 
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effects of ER and ER can occur either in the nucleus in the ‘classical’ fashion or at the 
membrane (Mermelstein & Micevych 2008), ER-X appears to act also largely at the 
membrane and to activate intracellular signaling cascades (Toran-Allerand et al. 2002; 
Qiu et al. 2003), whereas GPR30 is most highly expressed on the endoplasmic reticulum 
and acts to alter intracellular calcium signaling (Revankar et al. 2005). Interestingly, 
recent knockout mouse models show that ER is more closely coupled with 
masculinization and ERβ with defeminization (Kudwa et al. 2006).  
Many of sex differences are localized to regions that are necessary for adult sex 
behaviour or for determine the adult pattern of gonadotropin secretion. For instance, 
estradiol changes the preotic area (POA), a crucial region involved in many sex 
behaviours, including copulatory and maternal behaviours. In this area, multiple cell 
types, including neurons, astrocytes, and microglia are masculinized by estradiol. 
Specifically, in the POA normal males have twice the density of dendritic spines than 
females, and the density of dendritic spines on these neurons correlates with measures of 
adult male sexual behaviour. Estradiol administration to a newborn female induces the 
male pattern of dendritic spines (Wright et al. 2008). Multiple downstream molecular 
mediators are involved in this effect of estradiol, including prostaglandins, glutamate 
receptors, protein kinases, and several immune signaling molecules (Figure 2).  
Moreover, emerging evidence indicate epigenetic mechanism maintain sex differences in 
the POA that are organized perinatally and thereby produce permanent behavioural 
changes (Zhang & Ho 2011).  
 
Effect of estradiol administration during development 
Classical and recent studies have used different experimental paradigms to study sexual 
differentiation of the brain, including the prenatal or neonatal exposure of female rats to 
gonadal steroids. The first evidence of sexual differentiation of the brain was discovered 
in 1959, when Phoenix and colleagues reported that female guinea pigs, prenatally 
exposed to testosterone, showed little or no female sex behaviour as adults. One of the 
surprises was that treatment of neonatal females with exogenous estradiol, originally 
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administered as a control for testosterone, also induced complete masculinization of brain 
and behaviour (McEwen et al. 1977). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Rapresentation two different mechanisms of masculinization of the POA and the VMN 
induced by estradiol during the development period (from McCarthy et al. 2009). 
 
In the following years, numerous studies have examined the brain differentiation induced 
by estradiol, using different protocols. For example, neonatal administration of 100 µg of 
estradiol to female rats for five consecutive days after birth induces a premature vaginal 
opening and an altered estrous cycle with persistent estrus or prolonged estrus (Kouki et 
al. 2003). Similarly, a single injection of estradiol (100 µg) on the day of birth (Pinilla et 
al. 2002) or at day 5 after birth (Kanaya  Yamanouchi 2012) to female rats, causes 
alterations like acyclicity, anovulation, ovarian atrophy and loss of negative and positive 
feedback between estradiol and LH. Furthermore, treatment of newborn female rats with 
a low dose (10 µg) of estradiol benzoate for five consecutive days after birth, inhibits the 
growth and differentiation of the ovary (Ikeda et al. 2001). Similarly, the injection of 100 
µg of estradiol benzoate to female rats, 4 days after birth, abolished sexual receptivity in 
adulthood, even with estrogen and progesterone replacement after ovariectomy (Levine 
and Mullins 1964), while neonatal administration of a low doses of the 17-
ethinylestradiol, the main estrogen component in the contraceptive pill, alters female 
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sexual behaviour and specifically the appetitive components of sexual behaviour that 
influence the rate of copulation (Della Seta et al. 2008) Postnatal estradiol exposure 
during development also affected partner preference. In fact, female rats that received 
exogenous estradiol on postnatal day 0 and up to 3 weeks, spent more time with an 
estrous female and less time with a sexually active male (Henley et al. 2011).  
In addition, there are also numerous studies that have looked at the effects of androgens, 
aromatase inhibitors or environmental pollutants that show estrogenic action, also called 
xenoestrogens. If a developing female is exposed to testosterone propionate, she will be 
sterile, losing the capacity to ovulate and she will lack sexual receptivity as an adult 
(Barraclough 1961; Barraclough & Gorski 1961). Moreover, if as an adult she is treated 
with testosterone, she will exhibit male behaviour when presented with a sexually 
receptive female (Baum 1979; Whalen 1964). Neonatal exposure to genistein, a 
phytoestrogen found in soy-based foods, altered vaginal opening, induced an aberrant 
cycle with a persistent or prolonged estrus and caused the formation of small ovaries 
lacking corpora lutea (Kouki et al. 2003). Moreover, exposure to bisphenol A, a common 
environmental endocrine disruptor with estrogenic properties present in the manufacture 
of plastics used for containers, bottles, dental composites, and other plastics items 
induces lower levels of proceptive behaviour and a down-regulation of the estrogen 
receptor alpha expression in specific hypothalamic regions necessary for sexual 
receptivity and the lordosis posture (Monje et al. 2009). Overall, exposure to estrogen or 
estrogen-like compounds during development induces a broad spectrum of effects, which 
vary depending on dose and duration of exposure, age at exposure and sex of the 
individual.  
The neural mechanism underling the effects of a short exposure of developing females to 
estradiol at the level of genitalia and sexual behaviour have been extensively studied. 
Treatment of female neonates with testosterone or estrogen changes the responsiveness of 
the hypothalamus and pituitary gland to the feedback action of ovarian steroids, leading 
to dysregulation of the secretion of gonadotropin-releasing hormone (GnRH) and 
luteinizing hormone (LH), in adulthood (Robinson 2006). However, it is not clear 
whether these long-lasting effects that “program” the female neuroendocrine axis to 
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malfunction in adulthood have consequence in the brain hormonal milieu and/or in the 
behaviour influenced by gonadal hormones. 
The purpose of this thesis is to describe an animal model of defeminization induced by a 
single treatment with a low dose (10 µg) of β-estradiol-3-benzoate to female rats on the 
day of birth. We used β-estradiol-3-benzoate because it is the most commonly used ester 
of the naturally occurring estrogen estradiol in endocrine and neuroendocrine research 
involving estrogen replacement paradigms. In fact, this is a hormone that is rapidly 
hydrolyzed in vivo to the physiologically active 17β-estradiol following its systemic 
administration in oil. Firstly, we evaluated whether neonatal administration of β-
estradiol-3-benzoate changes the brain and plasma concentrations of gonadal hormones 
and their neuroactive steroid metabolites in the adult brain and alters the development of 
the female reproductive tract and the sexual behaviours (Chapter 1). Subsequently, we 
assessed whether this treatment may results in an alteration of behaviour through a series 
of behavioural tests that evaluate the emotional state, the cognitive function and the social 
behaviour in adulthood (Chapter 2). Moreover, given that we have recently demonstrated 
that neonatal administration of β-estradiol-3-benzoate alters the expression of specific 
GABAA receptor subunits (Calza et al. 2010), that may alter the behavioural sensitivity to 
GABAA receptor-targeting-drugs, such as benzodiazepines (Pritchett et al. 1989), we 
investigated whether sensitivity to diazepam in adulthood might be affected by neonatal 
administration of β-estradiol-3-benzoate (Chapter 3).  
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Chapter 1 
 
Characterization of an animal model of defeminization induced by a single 
treatment with β-estradiol-3-benzoate on the day of birth 
 
1.1 Introduction 
Abnormal levels of sex hormones in the perinatal period can induce profound alterations 
in neuroendocrine function, which have repercussions in adulthood for both reproductive 
and hormonal levels. These changes might involve alterations at every level of the 
hypothalamic-pituitary-gonadal axis. For example, estrogens may act on the 
hypothalamus by changing the release of gonadotropin-releasing hormone (GnRH), and 
thereby affecting gonadotropin and steroid hormone secretion; they may act on pituitary 
responsiveness to GnRH and thereby alter gonadotropin secretion and ovarian 
physiology; they may directly disrupt ovarian function, by inducing changes in ovarian 
cycle and steroid output. Moreover, it has been shown that treatment of female neonates 
with testosterone or estrogen changes the responsiveness of the hypothalamus and 
pituitary gland to the feedback action of ovarian steroids, leading to dysregulation of 
GnRH and the luteinizing hormone (LH) secretion in adulthood (Robinson 2006). This 
phenomenon results in adult females that exhibit persistent vaginal cornification, 
acyclicity and ovulatory failure associated with an altered production of steroids by the 
gonads (Handa et al. 1985; Rodriguez et al. 1993).  
Given that gonadal steroids, besides their role in the control of the reproductive function, 
affect the nervous system in many different ways, we evaluated whether the changes in 
the hormonal milieu induced by β-estradiol-3-benzoate administration to neonatal female 
rats might influence the brain and plasma concentrations of gonadal steroid and their 
neuroactive steroid metabolite, allopregnanolone, in the adult rat. Allopregnanolone has 
been proposed to be involved in neuroendocrine functions such as GnRH release (Vicems 
et al. 1994), gonadotropin release (Brann et al. 1990), inhibition of ovulation (Genazzani 
et al. 1995), modulation of female sexual behaviour (McCarthy et al. 1995), and the 
response to stress (Biggio et al. 2007). We also examined the effect of administration of a 
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single dose of β-estradiol-3-benzoate to neonatal female rats on estrus cycle and ovarian 
morphology in adulthood. 
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1.2 Materials and methods 
 
Animals 
Female Sprague-Dawley rats (Charles River, Calco, Italy) were bred in our colony and 
maintained on an artificial 12-h-light, 12-h-dark cycle (light on from 08:00 to 20:00 
hours) at a constant temperature of 22° ± 2°C and a relative humidity of 65%. Food and 
water were available ad libitum. Animal care and handling throughout the experimental 
procedures were in accordance with the European Communities Council Directive of 24 
November 1986 (86/609/EEC) and were approved by the local ethics committee. Females 
were mated with males at regular intervals. On the day of birth (day 0), the male pups 
were removed from the litter while the female pups were injected subcutaneously (s.c.) 
with 10 µg of β-estradiol 3-benzoate in 50 l of sesame oil or with 50 µl of sesame oil 
(controls) (Rodriguez et al. 1993; Solum and Handa 2002). In order to avoid leakage of 
β-estradiol 3-benzoate pups were injected under hypothermia anaesthesia. After injection, 
neonatal β-estradiol-3-benzoate-reated females were randomly distributed among litters 
of the same age so that each mother had five to eight pups. All female pups within a litter 
received the same treatment. After weaning, female rats were housed in groups (control 
and neonatal β-estradiol-3-benzoate-reated) of six to eight per cage. They were sacrificed 
on day 60 for measurement of plasma and brain steroid levels. To avoid effects of estrous 
cycle status and the stress of vaginal smears on steroid concentrations control animals 
were sacrificed in randomized phases of the estrous cycle. The female rats used for 
induced sexual behaviour were bilaterally ovariectomized (OVX) following anaesthesia 
with Equithesin (a mixture of Pentobarbital, ethanol 96% and chloral hydrate; 3ml/kg), 
three weeks prior to the behavioural tests. The vaginal cytology of the OVX rats 
confirmed that they were not cycling. 
 
Steroid extraction and assay 
Animals were sacrificed by decapitation, the brain was rapidly (<1 min) removed, and the 
cerebral cortex was dissected and frozen at −80°C until steroid extraction. Blood was 
collected from the trunk into heparinized tubes and centrifuged at 1000 × g for 15 min, 
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after which the plasma supernatant was frozen until assayed for steroids. All steroids 
were assayed in the same tissue sample. Steroids present in cerebral cortical homogenates 
(400 mg of tissue in 4 ml of phosphate-buffered saline) were extracted four times with an 
equal volume of ethyl acetate. The combined organic phases were dried under vacuum, 
the resulting residue was dissolved in 4 ml of n-hexane and applied to a Seppak silica 
cartridge (Waters, Milan, Italy), and residue components were eluted with a mixture of n-
hexane and 1-propanol (7:3, v/v). Steroids were further purified by HPLC on a 5-μm 
Lichrosorb-diol column (250 x 4 mm; Phenomenex, Castel Maggiore, BO, Italy) with a 
gradient of 1-propanol in n-hexane. Given that cholesterol, which coelutes from the 
Lichrosorb-diol column with progesterone, was found to reduce the sensitivity of the 
radioimmunoassay for progesterone, this latter steroid was separated from cholesterol by 
washing the corresponding dried column fractions twice with 200 μl of dimethylsulfoxide 
and once with 400 μl of water. Progesterone was extracted from the aqueous phase twice 
with 1.5 ml of n-hexane. The recovery of each steroid through the extraction-purification 
procedures (70 to 80%) was monitored by the addition of trace amounts (4000 to 6000 
cpm) of 
3
H-labeled standards to the brain tissue homogenate. Steroids were quantified by 
radioimmunoassay as described (Porcu et al. 2003). Plasma steroid concentrations, were 
measured in 1 ml after extraction with 1.5 ml of ethyl acetate for four times. 
 
Measurement of anogenital distance, vaginal opening and vaginal smear checks 
The anogenital distance in rats treated neonatally with β-estradiol-3-benzoate or with 
vehicle was measured on days 7, 21 and 60 after birth. All female pups were checked 
daily for vaginal opening. The differences in the anogenital distance and in the day of 
vaginal opening among the groups were detected by t-test. Vaginal smears were checked 
from vaginal opening until day 60. Every morning between 8:30 and 9:30 a.m. vaginal 
secretion from each animal was collected by carefully inserting the tip of a cotton swab 
(pre-wet in normal saline, NaCl 0.9%) into the vaginal orifice. It is important that the 
cotton swab is not inserted too deeply (more than 1 cm), in order to avoid excessive 
cervical stimulation, which may induce a pseudopregnancy state, characterized by a 
persistent diestrus (Goldman et al. 2007). Vaginal fluid was placed on glass slides and 
was observed under a light microscope. Three types of cells could be recognized: round 
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and nucleated ones are epithelial cells; irregular ones without nucleus are the cornified 
cells; and the little round ones are the leukocytes. The proportion among them was used 
for the determination of the estrous cycle phases (Long & Evans 1922; Mandl 1951). A 
female rat which showed a constant 4- or 5-day vaginal estrous cycle was regarded as an 
animal with a regular estrous cycle. When a vaginal smear contained cornified cells 
through the examination term, it was determined as persistent estrous, even if a few 
leukocytes were seen occasionally. If the diestrous condition appeared in some intervals 
in persistent estrous, the condition was regarded as a prolonged estrous. 
 
Hematoxylin & eosin staining of ovarian sections 
Rats (treated with β-estradiol-3-benzoate or vehicle) were ovariectomized at 60-70 days 
after birth during the estrous or diestrous phase of their cycle. The ovaries were fixed in 
4% paraformaldehyde in phosphate-buffered saline (PBS) through three consecutive 
steps: the first two steps were performed at room temperature for 1 hour each, the last 
step was performed at 4°C overnight. The tissue was then rinsed in PBS, dehydrated and 
embedded in paraffin. Ovarian tissue sections of 10 μm were prepared for hematoxylin & 
eosin (H&E) staining. Tissue sections of ovaries were deparaffinised in xylene, 
dehydrated through an ethanol series of 100%, 90%, 80%, 70%, and 50%, and stained 
with H&E. After dehydration and clearing with fresh xylene, sections were mounted with 
Canada balsam and observed on an inverted microscope in brightfield (ZEISS, Axio 
Observer Z.1). The images were acquired with a high resolution camera (ZEISS Axiocam 
MR-m) and were analyzed by Axiovision software to confirm the existence of corpora 
lutea (CL) and Graafian follicles (GF).  
 
Spontaneous sexual behaviour 
In order to evaluate the effect of neonatal treatment with β-estradiol-3-benzoate on sexual 
behaviour, each experimental animal was placed with a “vigorous” male in a cage, with 
clear plexiglass lids to allow videotaping with an 8 mm Sony Handycam (in nightshot) 
for subsequent analysis of female sexual behaviour. The experiment lasted overnight, for 
4 consecutive nights in order to capture the estrous cycle stage when females usually 
mate. The day before and the day after each mating, experimental animals were subjected 
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to vaginal smears in order to assess the stage of the cycle, given that females are 
receptive, and thus available to mate, only during the estrus phase. Each night, the male 
was placed in a cage with a different female, to promote the "Coolidge effect", whereby a 
male tends to mate more easily if it interacts with a different female.  
Behaviours were video recorded for analysis. Each female, was monitored for both 
receptive and proceptive behaviours. The receptivity is the “consummatory” component 
of sexual interaction, characterized by the lordosis posture, a postural reflex with a 
dorsiflexion of the vertebral column. The receptive behaviour is expressed through a 
lordosis quotient (LQ) (lordosis / mounts + intromissions X 100). Proceptive behaviours 
represent the “appetitive”, motivational component of sexual interaction and include 
those behaviours shown by a receptive female (in estrus) in order to attract and facilitate 
the male mounts such as “ear wiggling” (rapid oscillatory movement of the ears due to 
fast head movements subsequent to a high degree of tension in the axial muscles) and 
hops and darts (jumping and scattering in front of the male). 
 
Induced sexual behaviour  
Beginning at 90 days after birth, and 30 days after ovariectomy, estrus was induced in all 
females by administering estradiol (200 µg/rat, s.c.) and progesterone (500 µg/rat, s.c.), 
48 hours and 6 hours before the test, respectively. Lordosis and proceptive behaviours 
were examined for 60 minutes, under a dim red light, in a rectangular plexiglass mating 
arena (40 x 20 x 17 cm). A sexually vigorous male was allowed to acclimate to the 
testing chambers for 5 minutes before introducing the female. All tests were videotaped 
with a Sony Handicam (in nightshot) for subsequent analysis of female sexual behaviour 
as described above (LQ and proceptive behaviour). 
 
Reagents 
β-Estradiol 3-benzoate and Progesterone were obtained from Sigma-Aldrich (Milan, 
Italy). Antiserum to allopregnanolone was generated and characterized as described 
(Purdy et al. 1990). Antisera to progesterone and to 17β-estradiol were obtained from MP 
Biomedicals (Solon, OH, USA). All other chemicals were of the best available quality 
from commercial sources. 
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Statistical analysis 
Data are presented as means ± S.E.M. The statistical significance was assessed by t-test 
and one- or two-way analysis of variance (ANOVA) followed by the Newman-Keuls test. 
A p value of <0.05 was considered statistically significant. 
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1.3 Results and discussion  
 
Effect of neonatal administration of β-estradiol 3-benzoate on steroid hormone 
concentrations in rat plasma and cerebral cortex. 
In addition to its previously demonstrated effect on peripheral steroidogenic tissue 
(Rodriguez et al. 1993), we have now shown that neonatal administration of β-estradiol 
3-benzoate resulted in significant decreases in the plasma and cerebrocortical 
concentrations of progesterone (-94% and -58%, respectively, p<0.005) and its 
neuroactive metabolite allopregnanolone (-42% and -85%, respectively, p<0.0005) in 
female rats at 21 days after birth (Figure 1). Furthermore, administration of β-estradiol 3-
benzoate to female neonates induced pronounced decreases in the plasma and 
cerebrocortical concentrations of progesterone (-86 and -73%, respectively, p<0.001) and 
allopregnanolone (-92% and -58%, respectively, p<0.001) in female rats at 60 days after 
birth (Figure 2). In contrast, the same treatment had no significant effect on the plasma 
and cerebrocortical concentrations of 17β-estradiol (Figure 2).  
Figure 1. Effect of neonatal treatment with β-estradiol 3-benzoate on neuroactive steroid 
concentrations in rat plasma and cerebral cortex. Rats were injected with β-estradiol 3-benzoate 
(10 µg, s.c.) or vehicle (Control) on the day of birth and were sacrificed 21 days later for 
measurement of the plasma and cerebrocortical concentrations of progesterone and  
allopregnanolone. Data are expressed as nanograms of steroid per millilitre of plasma or as 
nanograms of steroid per gram of tissue and are means ± S.E.M. of values from 10 rats per group. 
*p< 0.005 and **p< 0.0005 versus the respective control value. 
Cerebral cortexPlasma
PROGESTERONE
(n
g
/m
l)
0,0
0,5
1,0
1,5
2,0
2,5
3,0
0,0
0,5
1,0
1,5
2,0
(n
g
/g
 o
f 
ti
ss
u
e)
*
**
Cerebral cortexPlasma
ALLOPREGNANOLONE
(n
g
/m
l)
0
1
2
3
4
5
0,0
0,5
1,0
1,5
2,0
Control
-Estradiol 
3-benzoate
(n
g
/g
 o
f 
ti
ss
u
e)
**
**
Chapter1  16 
 
 
 
Figure 2. Effect of neonatal treatment with β-estradiol 3-benzoate on neuroactive steroid 
concentrations in rat plasma and cerebral cortex. Rats were injected with β-estradiol 3-benzoate 
(10 µg, s.c.) or vehicle (Control) on the day of birth and were sacrificed 60 days later for 
measurement of the plasma and cerebrocortical concentrations of progesterone, allopregnanolone 
and 17β-estradiol. Data are expressed as nanograms of steroid per millilitre of plasma or as 
nanograms of steroid per gram of tissue and are means ± S.E.M. of values from 10 rats per group. 
*p< 0.001 versus the respective control value. 
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Neonatal exposure to exogenous estrogen is thought to program hormonal cyclicity in 
adulthood, at least in part by promoting the development of neuronal circuits that are 
resistant to the positive feedback actions of estrogen (Robinson 2006). This effect of 
estrogen impairs the ability of this steroid to stimulate the GnRH surge that is required to 
trigger the LH surge and subsequent ovulation. Exposure of female rat pups to 
testosterone or estrogen on postnatal days 1-10 thus renders them permanently incapable 
of undergoing the LH surge (Korenbrot et al. 1975) and, consequently, results in a lack of 
ovulation and an altered formation of the corpora lutea, the endocrine structures 
responsible for the production of progesterone (Handa et al. 1985; Rodriguez et al. 1993). 
Accordingly, our results show that both plasma and brain levels of progesterone are 
markedly reduced in rats treated with β-estradiol 3-benzoate while the concentration of 
estradiol was not affected by this treatment. This result is in agreement with the evidence 
that treatment with androgens or estrogens decreases the secretion of progesterone by the 
ovaries (Rodriguez et al. 1993), while prenatal exposure of female rats to exogenous 
androgen was previously found not to affect the serum concentration of estradiol in 
adulthood (Foecking et al. 2005).  
As a result of such impaired production of progesterone by the gonads, we have now 
found that the brain and plasma concentrations of its neuroactive steroid metabolite 
allopregnanolone are also reduced. Treatment with oral contraceptives, which reduces 
both the basal and stimulated serum concentrations of LH in rats, also results in 
decreased brain and plasma concentrations of progesterone and allopregnanolone in these 
animals (Follesa et al. 2002); it also prevents the increase in the serum concentrations of 
these steroids that normally occur in women during the luteal phase of the menstrual 
cycle (Rapkin et al. 2006). 
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Effect of neonatal administration of β-estradiol 3-benzoate on anogenital distance, 
vaginal opening and estrous cycle pattern. 
A method used to investigate the endocrine events and the integrity of the hypothalamic-
pituitary-ovarian reproductive axis in rodents is the assessment of changes in vaginal 
cytology during the estrous cycle. The reproductive cycle of female rats is called estrous 
cycle. Rats typically begin cycling immediately after the vaginal orifice opens, an event 
that occurs between postnatal days 32 and 36. Rats may initially show some irregular 
cycles (Goldman et al. 1985) before having a recurrent ovulation that occurs at either 4 or 
5 day intervals. The vaginal opening does not reflect the onset of sexual maturity. Several 
days or weeks may pass before the first ovulation, which is characterized by the presence 
of cornified cells in the vaginal smear. The estrous cycle is characterized by four phases: 
proestrus, estrus, metestrus and diestrus. Each phase differs based on the proportion 
among three types of cells observed in the vaginal smears: epithelial cells, cornified cells 
and leukocytes (Marcondes et al. 2002). A proestrus smear consists of predominance of 
round nucleated epithelial cells, which often have a granular appearance under the 
microscope. Proestrus lasts for one day and is followed by vaginal estrus, identifiable by 
the presence of large numbers of anucleated cornified cells, or cells with jagged edges. 
The predominance of cornified cells may last one day in a 4-day cycle, or may be present 
for two consecutive days in a 5-day cycle. A metestrus smear consists of the same 
proportion among leukocytes, cornified, and nucleated epithelial cells. A diestrus smear 
primarily consists of a predominance of leukocytes. The appearance of these cells 
typically correlates with the status of vaginal mucosa, uterus and ovaries and is linked to 
alterations in circulating concentrations of sex steroids and gonadotropins. In fact, the 
keratinization of vaginal epithelial cells that typically characterizes the day of estrus is a 
response to the rising level of estradiol that begins on the second day of diestrus and 
peaks around midday on proestrus (Pawluski et al. 2009). The term “estrus” refers to the 
“heat period” or sexual receptivity. The female rats are sexually receptive when small 
numbers of cornified cells begin to appear (Young et al. 1941; Rodgers 1970; Hardy 
1972), an event that occurs at the end of the day of vaginal proestrus, exactly when the 
ovulation takes place. 
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In order to further characterize the effects of neonatal administration of β-estradiol 3-
benzoate on the hypothalamic-pituitary-ovarian reproductive axis, we examined the 
development of the reproductive tract and the estrus cycle in the rats treated with β-
estradiol 3-benzoate. 
All animals have been monitored from the day of birth (day 0) until day 60 to check for 
anogenital distance, vaginal opening and to subsequently perform vaginal smears. There 
was no difference in anogenital distance between control and β-estradiol 3-benzoate-
treated rats at 7 and 21 days after birth. 60 days after birth β-estradiol 3-benzoate-treated 
rats showed a significant increase in the anogenital distance with respect to control 
animals (from 16 to 18 cm, p<0.05) (Table 1).  
 
Table 1. Effect of neonatal treatment with β-estradiol 3-benzoate (EB) on  anogenital distance, 
vaginal opening and estrous cycle in female rats. 
 
Rats were injected with EB (10 µg, s.c.) or vehicle (Control) on the day of birth. Data are means 
± S.E.M. from 10 rats per group. *p<0.05; **p<0.0005 versus the respective control group. 
 
 
Furthermore, neonatal β-estradiol 3-benzoate treatment induced a delay in the vaginal 
opening from day 31 to day 44 (p<0.0005). Changes in vaginal cytology during the 
estrous cycle were monitored from the day of vaginal opening until day 60 after birth. A 
regular estrous cycle was observed in all control animals. In contrast, ten out of ten β-
estradiol 3-benzoate-treated rats showed a prolonged estrus, with a diestrous condition 
appearing occasionally, suggesting that a single administration of β-estradiol 3-benzoate 
on the day of birth compromises the estrus cycle in adult female rats. Given that the 
keratinization of vaginal epithelial cells that typically characterizes the day of estrus is a 
response to the rising level of estradiol (Pawluski et al. 2009), the persistent presence of 
Neonatal 
treatments 
N° of 
rats 
Anogenital 
distance (cm) 
Vaginal 
opening 
Estrous cycle 
  60 days (Median day) Regular Irregular 
     
Prolonged 
estrus 
Persistent 
estrus 
Control 10 16 ± 0.25 31 ± 0.58 10/10 0/10 0/10 
EB 10 18 ± 0.67* 44 ± 1.15** 0/10 10/10 0/10 
Chapter1  20 
 
keratinized cells and the predominance of the estrous phase observed in β-estradiol 3-
benzoate-treated rats could be related to the finding that 17β-estradiol concentrations 
were not affected by this treatment. Moreover, we found that, the neonatal treatment with 
β-estradiol 3-benzoate decreased progesterone levels in the adult animal. Progesterone 
plays an essential role in the second half of the cycle, by promoting the optimal 
conditions for fertilization and implantation of the egg cell. Therefore, the persistence of 
the estrous phase and the lack of the cyclic alternation of the other phases, could be due 
to the unchanged estradiol concentrations and reduced levels of progesterone present in 
these animals. 
 
Effect of neonatal administration of β-estradiol 3-benzoate on morphology and 
histology of the uterus and ovaries in adult female rats. 
Next we examined whether the dysregulation of the estrous cycle induced by neonatal 
treatment with β-estradiol 3-benzoate might result in alterations of the ovarian 
morphology. As expected (Bloch et al. 1995), there was no difference in weight between 
the left and right ovary. In the β-estradiol 3-benzoate-treated rats, mean uterus and 
ovaries weights were less than half compared to values observed in the control groups 
(EB: 0.51±0.08g; Co: 1.71±0.09g, p<0.001). Ovarian weight is influenced by the size and 
number of Graafian follicles and of corpora lutea which are in turn influenced by 
circulating LH and FSH.  
Histological examination of the ovaries showed that all control rats showed a remarkable 
number of follicles at different stages of maturation and the presence of corpora lutea. On 
the contrary, β-estradiol 3-benzoate-treated rats exhibited a different histological pattern 
characterized by a marked reduction in the number of corpora lutea and an increase in the 
number of large follicles with a hypertrophic granulosa layer. Accordingly, 
administration of a high dose (100 µg) of estradiol for five days after birth to female rats 
induced profound alterations in the ovarian histology, with a lack of corpora lutea and a 
predominance of large follicles (Kouki et al., 2003). Given that the primary function of 
the corpus luteum is the secretion of progesterone, the almost total absence of this 
endocrine structure in the ovary of β-estradiol 3-benzoate-treated rats could be 
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responsible for the dramatic reduction of brain and peripheral levels of progesterone and 
its metabolite allopregnanolone.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effect of neonatal treatment with β-estradiol 3-benzoate on histology of the uterus and 
ovaries in adult female rats. Rats were injected with β-estradiol 3-benzoate (10 µg, s.c.) or 
vehicle (Control) on the day of birth. The ovaries from β-estradiol 3-benzoate-treated rats and 
from control females exhibited a different histological pattern during the estrous cycle. Of note, 
the increased number of large follicles (LF) and the decreased number of corpora lutea (CL) in β-
estradiol 3-benzoate-treated female rats. Control females showed follicles at different stages of 
maturation (F), in particular Graafian follicles (GF). 
 
 
Effect of neonatal administration of β-estradiol 3-benzoate on spontaneous and 
induced sexual behaviour in adult female rats. 
Neuroendocrine and anatomical alterations induced by neonatal administration of β-
estradiol 3-benzoate also affect sexual behaviour in the adult. This is known since 1963, 
when Whalen and Nadler showed that neonatal treatment with high doses of estrogen for 
five days significantly reduced lordosis behaviour in adult female rats. Thus, we assessed 
whether both spontaneous and induced sexual behaviours were affected in adult female 
rats following neonatal exposure to β-estradiol 3-benzoate. Female rats engage in 
proceptive and receptive sexual behaviours. Proceptive behaviours involve the 
solicitation of sexual activity (hopping, darting and ear wiggling), whereas receptive 
behaviours ensure that mating is successful (lordosis). Several papers have documented 
LF 
Control β-Estradiol 3-benzoate 
F 
F 
GF 
CL 
LF 
LF 
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that proceptive behaviours were controlled by progesterone, while the expression of 
receptive behaviours was amplified by a combination of estrogen and progesterone 
(Feder 1984). In agreement, ovariectomized females do not display proceptive or 
receptive behaviours in the presence of a male (Boling and Blandau, 1939). As expected, 
neonatal administration of β-estradiol 3-benzoate to female rats affected the spontaneous 
sexual behaviour in adulthood. In fact, this treatment induced a marked decrease of the 
lordosis quotient (-93%, p<0.05) and of the proceptive behaviours (-99%, p<0.05) 
(Figure 4) with respect to control animals that showed a regular mating during their 
estrous cycle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Effect of neonatal administration with β-estradiol 3-benzoate on spontaneous sexual 
behaviour of adult female rats. Rats were injected with β-estradiol 3-benzoate (10 µg, s.c.) or 
vehicle (Control) on the day of birth and were tested for sexual behaviour overnight, for 4 
consecutive nights, between days 60 and 90 after birth. Each female was placed in a testing arena 
with a sexually experienced male. For each female, a lordosis quotient (LQ) (number of lordosis 
displayed/number of mounts x 100) was calculated and proceptive behaviours (ear wiggling, 
hops and darts) were monitored. Data are means ± S.E.M. from ten rats per group. *p<0.05 
versus the respective control value. 
 
Next we evaluated whether the induction of estrus stage in the β-estradiol 3-benzoate-
treated females was able to enhance sexual behaviour and actively promote mating with 
the male. All rats were bilaterally ovariectomized one month before the test. For the 
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experiment, they were injected with estradiol benzoate and progesterone 48 hours and 6 
hours before mating, respectively. As expected (Xiao & Becker 1997; Blaustein & Wade 
1977), this treatment induced lordosis and proceptive behaviours in control animals. On 
the contrary, neonatal β-estradiol 3-benzoate-treated rats, showed a severe decrease of the 
lordosis quotient (97%, p<0.0001) and of proceptive behaviours (-100%, p<0.0001), 
compared to control rats (Figure 5), an effect similar to that observed during the 
spontaneous sexual behaviour evaluation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Effect of neonatal administration of β-estradiol 3-benzoate on induced sexual 
behaviour. Rats were injected with β-estradiol 3-benzoate (10 µg, s.c.) or vehicle (Control) on the 
day of birth and were tested for sexual behaviour for 60 min between days 60 and 90 after birth. 
To induce estrous, EB (200 µl/rat, s.c.) and progesterone (500 µg/rat, s.c.) were administered 48 
hours and 6 hours before the test, respectively. Each female was placed in a testing arena with a 
sexually experienced male. The lordosis quotient (LQ) (number of lordosis displayed/number of 
mounts x 100) was calculated and the proceptive behaviours (ear wiggling, hops and darts) were 
monitored. Data are means ± S.E.M. from ten rats per group. *p<0.0001 versus the respective 
control value. 
 
Therefore, the injection of a low dose of β-estradiol 3-benzoate (10 μg) to female rats on 
the day of birth, abolishes sexual receptivity in adulthood, similar to what has been 
previously reported for the higher dose of 100 μg (Levine and Mullins, 1964). This effect 
persists, even when estrogen and progesterone are administered to induce estrus after 
ovariectomy. In contrast, in ovariectomized rats the administration of estradiol and 
progesterone restores sexual behaviour (Levine and Mullins, 1964).  
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Overall these results suggest that the administration of a low dose of β-estradiol-3-
benzoate, such as 10 μg, is sufficient to androgenize the sexually dimorphic brain regions 
responsible for sexual behaviour. Therefore, this model can be used to study the 
phenomenon of defiminization of the developing brain. 
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Chapter 2 
 
Effect of neonatal estradiol treatment on emotional, cognitive and social behaviours in 
adult rats 
 
2.1 Introduction 
 
The 3,5-reduced metabolite of progesterone, allopregnanolone, is a neurosteroid that 
exerts a rapid change in neuronal excitability and elicits behavioural effects of its 
administration to experimental animals (Biggio and Purdy 2001). Our understanding of 
the physiological role of this endogenous neuroactive steroid was greatly increased by the 
finding that allopregnanolone is the most potent and efficacious positive allosteric 
modulator of gamma-aminobutyric acid type A (GABAA) receptor function (Majewska 
1992; Lambert et al. 1995). In fact, the interaction between allopregnanolone and the 
GABAA receptor appears to underlie the pharmacological actions of this steroid that are 
similar to those induced by classical positive modulators of GABAA receptors such as 
benzodiazepines. Allopregnanolone can be directly synthesised in the brain, in addition to 
peripheral sources; however, the corpus luteum contribution of progesterone and 
allopregnanolone to the peripheral plasma also augments brain concentrations of this 
neuroactive steroid (Biggio and Purdy 2001; Ottander et al. 2005). Given that GABAA 
receptors participate in the regulation of a variety of psychophysiological phenomena, 
including anxiety, depression, sleep, cognitive function, seizures, social and sexual 
behaviour, such fluctuations in the concentrations of allopregnanolone may play a crucial 
role in the cognitive and psychiatric manifestations of conditions characterized by 
marked changes in the hormonal milieu. In fact, animal studies have shown that 
allopregnanolone, administered systematically or intracerebroventricularly, elicits 
anxiolytic, antidepressive, anticonvulsant and sedative-hypnotic effects similar to those 
induced by benzodiazepines (Biggio and Purdy 2001). Moreover, allopregnanolone 
facilitates social and sexual behaviour and exhibits analgesic and neuroprotective actions 
(Frye et al. 2009; Jevtovic-Todorovic et al. 2009; Djeballi et al. 2005; Wang et al. 2005). 
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On the other hand, a number of reports have indicated that allopregnanolone may also 
have some non-beneficial effects. In fact, allopregnanolone has been shown to induce 
irritability/aggression (Miczek et al. 1997; Fish et al. 2002), and it has been reported to 
induce anxiety following a short-term treatment (Gulinello et al. 2001). Moreover, 
allopregnanolone has been described to have a detrimental learning profile when injected 
systemically (Johansson et al. 2002) or directly into the brain (Mayo 1993; Ladurelle et 
al. 2000). Accordingly, it has been shown that the administration of allopregnanolone 
impairs episodic memory in women (Kask et al. 2008).  
Several findings indicate that allopregnanolone plays an important role during brain 
development (Mameli et al. 2005). In fact, it has been described that neonatal 
allopregnanolone promotes the establishment of neuronal circuitry and supports the 
survival of developing neurons (Griffin et al. 2004). Also, previous studies demonstrated 
that alterations in neonatal allopregnanolone levels have a profound effect on the 
morphology and the structure of several brain areas such as the cortex and the thalamus 
(Grobin et al. 2003; Grobin et al. 2004; Grobin et al. 2006); in addition they also 
critically alter the normal development of the hippocampus (Cooper et al. 1999). 
Accordingly, alterations in adult behaviour have also been reported. Thus, manipulation 
of neonatal allopregnanolone levels alters the performance in the elevated plus maze and 
the aversive learning in the passive avoidance test (Martin-Garcia et al. 2008). In 
addition, allopregnanolone administration from postnatal day 5 to postnatal day 9 has 
been shown to alter responses to GABAA modulators (such as benzodiazepines) during 
adulthood (Darbra et al. 2009), and to induce an anxiolytic profile in the elevated plus 
maze (Darbra et al. 2012). All together these evidences suggest that alteration of 
allopregnanolone during critical developmental periods have important consequences in 
adult behaviour. 
On the basis of these evidences, given that treatment of female rats with β-estradiol 3-
benzoate on the day of birth induces a dramatic reduction of the brain and plasma levels 
of allopregnanolone in adulthood, one of the aims of this thesis was to assess whether this 
treatment might modify several emotional, cognitive and social behaviours. Specifically, 
rats underwent the elevated plus maze test to evaluate anxiety levels, the motility meter 
test to evaluate the locomotor activity, the Porsolt test to assess depression, 
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pentylentetetrazole (PTZ)-induced convulsions to assess seizures sensitivity, the Morris 
water maze test to evaluate learning and memory and the resident-intruder test to 
investigate the agonistic and social behaviours. 
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2.2  Materials and methods 
 
Animals 
Animal care and handling throughout the experimental procedures and neonatal treatment 
with β-estradiol 3-benzoate were performed as described in chapter 1. The animals were 
subjected to behavioural tests between days 60 and 90 after birth. To avoid effects of 
estrous cycle status we tested control animals in randomized phases of the estrous cycle. 
The female rats used as intruders, as mates of interaction and as receptive female were 
bilaterally ovariectomized (OVX) as described in chapter 1. 
 
Elevated plus-maze test 
The plus-maze was made of black polyvinyl chloride and comprised two open and two 
closed arms (12 x 60 cm) connected by a central square (12 x 12 cm) that served as the 
start point (Figure 1). The apparatus was mounted 50 cm above the floor of a quiet, dimly 
lit room. On the test day, rats were allowed to acclimate to the experimental room for 1 
hour before the test. Each rat was tested only once. The animal was placed at the start 
point of the maze facing an open arm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Elevated Plus-Maze apparatus 
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During the 5-min test, the number of entries into open and closed arms and the time spent 
in each type of arm were monitored for each rat by two observers unaware of the 
treatment group; arm entry was defined as the presence of all four feet of the animal in 
the arm. Rats were tested in a randomized order between 09.00 and 14.00 hours. Tests 
were performed during the light period of the light-dark cycle. The maze was cleaned 
thoroughly at the end of each test. 
 
 
Locomotor activity test 
Locomotor activity of rats was assessed with the use of a Digiscan Animal Activity 
Analyzer (Omnitech Electronics, Columbus, OH, USA). The test chamber consists of a 
cubicle made of clear Perspex (48 x 50 cm) and with 50-cm high walls (Figure 2). Two 
facing blocks containing an infrared array record horizontal activity, and a similar system 
assesses vertical activity. Each animal was gently placed at the centre of the chamber and 
allowed to explore the apparatus in an illuminated and quiet room. Locomotor activity 
was recorded during the light cycle between 09.00 and 14.00 hours. Rats were tested in a 
randomized order, and locomotor activity was assessed for each animal individually 
during a 10-min period. The total distance travelled (cm) by each animal was 
accumulated over consecutive 2-min time windows, and the number of movements was 
recorded. The arena was cleaned thoroughly at the end of each test. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Motility meter apparatus. 
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Porsolt test  
The forced swim test or Porsolt test (Porsolt et al. 1977) is also called behavioural despair 
test and it is usually used to evaluate the antidepressant activity of drugs. The apparatus 
consists of a clear acrylic cylinder, 18 cm in diameter and 40 cm in height, filled with 
water at room temperature (25°C) to a depth of 15 cm (Figure 3). The rat is placed into 
the cylinder from which there is no chance to escape, so he is forced to stay afloat or 
swim for 5 minutes. After a short period of hyperactivity, the animals stay in an immobile 
position and they no longer try to escape. Immobility in the water is considered an index 
of depressed mood and antidepressant drugs tend to reduce the immobility time. Testing 
was conducted over two consecutive days. On day 1 (pre-test), rats were placed in the 
cylinder for 10 minutes, to adapt to the experimental room before the test. On day 2, 24 
hours after the pre-test, rats were placed in the cylinder for 5 minutes. Movements were 
recorded using a video camera and DVD recorder. Scoring was performed by an observer 
unaware of treatment group. Immobility duration was scored on day 2 as time spent not 
swimming or reaching at the walls. The test was performed during the light cycle 
between 09.00 and 14.00 hours. The acrylic cylinder was cleaned thoroughly at the end 
of each test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Porsolt apparatus 
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PTZ-induced seizures  
The sensitivity of the animals to seizures was evaluated using pentylentetetrazole (PTZ) 
(Depoortere et al. 1986). This convulsant drug, when injected intraperitoneally at the 
dose of 60 mg/kg induces generalized tonic-clonic convulsions sometimes leading to 
death within a few seconds in control rats. PTZ was dissolved in distilled water and was 
injected i.p. at a dose of 60 mg/kg in a volume of 3 ml/kg. Control animals received the 
same volume of vehicle. Rats were observed for 30 minutes following PTZ injection. The 
latency to appearance of seizures, the number of rats showing seizures and the number of 
deaths were recorded. 
 
Morris water maze  
The Morris water maze is a test of spatial learning introduced almost 30 years ago by 
Richard Morris (Morris 1984). It consists of a circular pool (150 cm in diameter, 60 cm in 
depth) whose interior is painted black. The apparatus was located at the centre of a room 
dedicated to measurement of this behavioural paradigm. The water temperature was 
maintained at 25 ± 2°C with the use of a submersible digital water-heating system. The 
pool was divided into four virtual quadrants, and a removable circular escape platform 
(10 cm in diameter, 32 cm in height) was introduced into one of the quadrants (target 
quadrant) at a depth of 2 cm below the water surface. The protocol we followed consisted 
of a training phase and a probe trial. Over five consecutive days, each rat was subjected 
to four training trials, in which it was placed into the pool in the quadrant next to the 
target quadrant. Once the animal had climbed onto the platform, it was allowed to remain 
there for 15 seconds before the next trial; if it had not found the escape platform by 120 
seconds, it was gently guided to the platform and allowed to rest there for 15 seconds. 
The time elapsed (latency) before the animal climbed onto the platform, swim speed, and 
distance travelled during each trial were recorded; animals that did not climb onto the 
platform before the end of the trial period were assigned a latency value of 120 seconds. 
To assess the long-term spatial memory at 24 hours after the last training trial, each rat 
was subjected to a probe trial, in which the escape platform was removed from the pool 
and the animal was released from the quadrant opposite to the original platform location 
and allowed to freely swim for 60 seconds. Behavioural data from the training and probe 
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tests were acquired and analyzed using an automated tracking system (Ethovision, 
Noldus, Wageningen, The Netherlands). Using this software, the precise rat location (in 
x, y coordinates) was recorded throughout the probe test (capture rate 10 frames/seconds). 
From this spatial distribution, proximity measure (Gallagher et al. 1993) was calculated 
automatically. For the probe trial, the tracking software virtually divided the pool into 
four quadrants, three concentric annuli and a target region consisting of the intersection 
of the platform quadrant and the platform annulus (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Resident-intruder test 
Animals were assessed for the display of offensive aggressive behaviours against an 
unfamiliar conspecific intruder using a standard resident-intruder aggression test 
(Koolhaas et al. 1980). This type of aggression test is the most frequently used 
methodological approach in the laboratory because resident-intruder paradigms have a 
very wide species generality (Adams 1979; van Hooff 1977; Wilson 1975). Subjects were 
80 female rats. Forty rats, ovariectomized 3 weeks before the experiment, were used as 
intruders. The use of OVX female intruders eliminates the estrous cycle variability that 
North 
South West 
East 
Platform location 
Target region 
Central ring 
Platform ring 
Peripheral ring 
Figure 4. Schematic representation of the virtual division of the water 
maze used to asses memory performance. 
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has been shown to affect aggression in rats (Ho et al. 2001). The remaining 40 female rats 
were used as residents. 7 days before the test, the female rats to be tested as residents 
were isolated and their cages were no longer changed or cleaned in order to allow them to 
establish a territory in their home cages. On the test day, the OVX female intruder (same 
size as the resident) was introduced in the resident’s home cage. The rats were left 
undisturbed to freely interact for 10 minutes while being videotaped. Social interactions 
between residents and intruders took place during the dark phase of the light/dark cycle. 
Clear Plexiglas lids were used to allow videotaping from above with an 8 mm Sony 
Handicam (in nightshot) for subsequent behavioural analysis of the interactions. To assist 
in identification, the intruder rats were painted with black magic marker at least 12 hours 
prior to testing. At this time, all residents and intruders were moved into the testing room 
and left undisturbed for at least 12 hours. The videotaped social interactions were scored 
by one trained observer that was unaware of the animals’ group. The interactions were 
analyzed for 21 behaviours based on the ethogram by Grant and Mackintosh (1963; see 
Table 1, modified from Clipperton et al. 2008, for behaviour descriptions) using the 
Behaviour Tracker software. The behavioural analysis focused on the treated rat, the 
resident. The behaviour of the intruder was collected only in relation to the behaviour of 
the resident (i.e., attacks received, reciprocal attacks, social inactivity), and in the 
reciprocal pairs of behaviours (dominant/submissive behaviour and chasing/avoidance of 
the intruder). Moreover, different categories of individual behaviours were formed 
(modified from Clipperton et al. 2008) to provide an overall view of the animals’ 
behaviour. 
 
 
Statistical analysis 
Data are presented as means ± S.E.M. The statistical significance was assessed by t-test 
and one- or two-way analysis of variance (ANOVA) followed by the Newman-Keuls test. 
A p value of <0.05 was considered statistically significant. 
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Table 1. Description of scored behaviours in the resident-intruder test. 
  
Agonistic behaviours delivered   
Follow intruder The resident rat actively follows, or pursues and chases the intruder; 
reciprocal to avoid. 
Dominant behaviours The resident rat is in control; includes pinning of the intruder, 
aggressive grooming, crawling over or on top, and mounting attempts. 
Attacks delivered Physical attacks, including dorsal/ventral bites. Only the frequency of 
attacks was measured. 
  
Agonistic behaviours received   
Avoidance of the intruder   The resident withdraws and runs away from the intruder while the 
intruder is chasing. 
Submissive behaviours The intruder rat is in control; includes crawl under, supine posture 
(ventral side exposed), prolonged crouch, and any other behaviour in 
which the intruder is dominant (e.g., the intruder pins, aggressively 
grooms, etc., the resident). 
Attacks received Physical attacks including bites to dorsal/ventral regions. Only the 
frequency of attacks was measured. 
Defensive upright posturing Species-typical defensive behaviour; upright with the head tucked and 
the arms ready to push away. 
  
Dominance score  Total agonistic behaviour delivered minus total agonistic behaviour 
received. A negative score indicates that the resident was the 
submissive animal in the pair, while a positive score signifies that the 
resident was the dominant animal. 
  
Social investigation  
Oronasal investigation Active sniffing of the intruder’s oronasal area. 
Body investigation Active sniffing of the intruder’s body. 
Anogenital investigation Active sniffing of the intruder’s anogenital region. 
Approaching and/or attending to 
the intruder 
Often from across the cage; the resident’s attention is focused on the 
intruder, head tilted toward the intruder and movements toward the 
intruder; this becomes ‘‘chasing the intruder’’ once along the tail or 
sniff if resident is within 1.5 cm of the intruder. 
  
Non-social behaviours   
Horizontal exploration Movement around the cage; includes active sniffing of air and ground. 
Vertical exploration Movement to investigate upwards, both front feet off the ground; 
includes sniffing, wall leans and lid chews. 
Digging  Rapid stereotypical movement of forepaws in the bedding. 
Abnormal stereotypies ‘‘Strange’’ behaviours, including spinturns, repeated jumps/lid 
chews/head shakes. 
Solitary inactivity No movement; includes sit, lie down and sleep. 
Self-groom Rapid movement of forepaws over facial area and along body. 
 
Chapter2  35 
 
2.3 Results and discussion  
 
Effect of neonatal administration of β-estradiol 3-benzoate on the behaviour of rats 
in the elevated plus maze, motility, Porsolt test and PTZ-induced seizures 
Neonatal administration of β-estradiol 3-benzoate did not affect the behaviour of adult 
female rats in the elevated plus maze test. In fact, the percentage of time spent in the open 
arms and the percentage of open-arm entries did not differ between control and β-
estradiol 3-benzoate-treated rats (Table 2). This test is based on the normal rat's aversion 
toward an open environment. Usually, rodents spend less time and make fewer entries 
into the open arms of the maze; therefore, a higher percentage of time spent in the open 
compartment implies a lower level of anxiety. The lack of changes in anxiety like-
behaviour between β-estradiol 3-benzoate- and vehicle-treated rats may indicate that the 
decrease in the concentrations of allopregnanolone and progesterone, induced by neonatal 
β-estradiol 3-benzoate treatment, might not account for changes in the emotional state of 
the animals in adulthood. These results are in contrast with previous observations 
showing that decreased levels of allopregnanolone induced by ovariectomy or by 
administration of the 5α-reductase blocker finasteride increase anxiety-like behaviour in 
the elevated plus-maze paradigm (Zimmerberg and Farley 1993; Smith et al. 1998b). 
Accordingly, administration of oral contraceptives, a treatment that markedly decreases 
brain allopregnanolone concentrations, enhances anxiety levels in the elevated plus maze 
paradigm (Follesa et al. 2002). Furthermore, both progesterone and allopregnanolone, 
when injected systemically or intracerebroventricularly, induce anxiolytic effects in 
various behavioural tests (Bitran et al. 1991, 1993; Wieland et al. 1991; Zimmerberg et 
al. 1994).  
Consistent with the results obtained in the elevated plus maze test, neonatal estradiol 
treatment did not affect the locomotor activity of adult female rats in the motility meter 
test. In fact, we did not find statistically significant differences between the two 
experimental groups in the total distance travelled and in the number of movements 
(Table 2). 
Clinical and animal studies support a role of allopregnanolone in depressive behaviours. 
Indeed, decreased plasma and cerebrospinal fluid concentrations of allopregnanolone 
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have been detected in major depressive disorder (Uzunova et al. 2003). Moreover, it has 
been shown that administration of drugs with clinical relevance in the treatment of these 
pathologies influences the secretion of these steroids (Dubrovsky 2005; Pisu and Serra 
2004).  
 
Table 2. Effect of neonatal treatment with β-estradiol 3-benzoate on the behaviour of adult 
female rats in different tests 
 
Tests Parameters Control β-Estradiol 3-benzoate 
    
Plus maze % time in open arms 13.2 ± 2.7 11.2 ± 2.5 
    
  % open-arm entries 17.1 ± 2.9 13.4 ± 2.9 
        
    
Motility Total distance travelled (cm)  1935.1 ± 283.9 2471.7 ± 303.2 
    
 No. of movements  70.2 ± 6.4 77.7 ± 7.4 
        
    
Porsolt Immobility (sec) 86.1 ± 10.2 95.2 ± 8.5 
    
 Diving 1.5 ± 0.6 0.9 ± 0.4 
    
 Swimming (sec) 213.9 ± 9.8 204.8 ± 7.8 
        
    
PTZ seizures Animals showing convulsions 7/7 8/8 
    
  Latency (sec) 112 ± 12 111 ± 15 
 
Rats were injected with β-estradiol 3-benzoate (10 µg, s.c.) or vehicle (Control) on the day of 
birth and underwent to the elevated plus maze test, motility meter test, forced swim test and PTZ-
induced seizures between days 60 and 90 after birth. Data are means ± S.E.M. of values from 15 
rats per group (elevated plus maze and forced swim tests), 10 rats per group (motility meter test), 
8 rats per group (PTZ-induced seizures). 
 
In addition, allopregnanolone has been shown to elicit an antidepressant effect in the 
forced swim test (Kisthi et al. 2000). Therefore, given that neonatal treatment with β-
estradiol 3-benzoate decreases allopregnanolone levels in the adult female rats, we 
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evaluated whether this treatment would affect the forced swim test that measures 
behavioural despair in rodents as an index of depression. As shown in table 2, we 
observed no significant alterations in the time of immobility and in the number of dives, 
measured in adult females that had been treated with β-estradiol 3-benzoate on the day of 
birth, suggesting that the decrease in brain allopregnanolone levels, induced by neonatal 
treatment with β-estradiol 3-benzoate, does not affect behavioural despair in adult rats. In 
contrast, ovariectomy, which also decreases brain allopregnanolone content (Follesa et al. 
2002), increases depressive behaviour in female rats (Frye and Wawrzycki 2003) and 
administration of progesterone and allopregnanolone can reverse these effects (Frye and 
Walf 2002). 
Finally, neonatal administration of β-estradiol 3-benzoate did not affect the sensitivity of 
the animal to the convulsant effect induced by PTZ. In fact, both β-estradiol 3-benzoate- 
and vehicle-treated rats showed seizures after administration of PTZ (60 mg/kg, i.p.), 
with a similar latency of onset (Table 2). Again, this result is at odd with the evidence of 
the protective actions of allopregnanolone against several standard convulsive tests in 
rodents (Gasior et al. 1997). 
Overall, although allopregnanolone seems to be involved in different psychiatric and 
neurological disorders including anxiety, depression and epilepsy, the lack of differences 
in the above behavioural analyses between neonatal β-estradiol 3-benzoate-treated rats 
and the respective controls does not support a role for allopregnanolone in mediating the 
behaviour in these animals.   
 
 
Effect of neonatal administration of β-estradiol 3-benzoate on the behaviour of rats 
in the Morris water maze test in adult female rats. 
Given that allopregnanolone administration decreases spatial learning in the Morris water 
maze (Johansson et al. 2002) and rats treated on the day of birth with β-estradiol 3-
benzoate have lower levels of this neurosteroid, we evaluated the effect of neonatal 
treatment with β-estradiol 3-benzoate on this behavioural test. The Morris water maze is a 
test used to study spatial learning and memory, introduced almost 30 years ago by 
Richard Morris (Morris 1984), where rats are trained to locate a hidden escape platform 
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that is positioned just below the water surface. In our experiment, all rats appeared to 
swim normally and showed no difficulty in locating the hidden platform provided. 
During the 4 training trials both control and neonatal β-estradiol 3-benzoate-treated rats 
showed a decrease in the latency to locate the hidden platform, but we did not observe 
any treatment differences (Figure 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Effect of neonatal treatment with β-estradiol 3-benzoate on learning performance in the 
Morris water maze test in adult female rats. Rats were injected with β-estradiol 3-benzoate (10 
µg, s.c.) or vehicle (Control) on the day of birth and were tested in the Morris water maze test 
between days 60 and 90 after birth. The time elapsed (latency) to reach to the platform was 
recorded as an acquisition parameter. Data are means ± S.E.M. of values from 9 rats per group 
(repeated-measures ANOVA). 
 
 
Accordingly, during the probe trial, when the hidden platform was removed to evaluate 
spatial memory retention, neonatal β-estradiol 3-benzoate-treated rats did not show a 
better performance in their ability to locate the original platform location. In fact, 
although in neonatal β-estradiol 3-benzoate-treated rats there was a trend towards a lower 
latency to reach the area where the platform used to be, and β-estradiol 3-benzoate-
treated rats spent more time in the platform quadrant, these differences did not reach 
AQUISITION
Training day
1 2 3 4
la
te
n
cy
 t
o
 p
la
tf
o
rm
 (
s)
0
20
40
60
80
Control
-Estradiol 3-benzoate
Chapter2  39 
 
statistical significance. Moreover, there were no differences between the two 
experimental groups in the other parameters measured (Table 3).  
 
Table 3. Effect of neonatal treatment with β-estradiol 3-benzoate on memory performance in the 
Morris water maze test in adult female rats. 
 
PROBE TRIAL Control β-Estradiol 3-benzoate 
Whole water maze parameters   
Distance (m) 12.50 ± 0.59 13.09 ± 0.64 
Platform parameters   
No. of entries  2.62 ± 0.67 2.29 ± 0.18 
Latency (s) 21.17 ± 7.30 8.59 ± 1.56 
Platform quadrant parameters   
No. of entries (m) 3.88 ± 0.48 4.14 ± 0.34 
Time (s) 15.35 ± 2.00 21.73 ± 2.46 ϯ 
Latency (s) 5.82 ± 1.10 4.96 ± 0.59 
Target region parameters   
Time (s) 7.99 ± 1.40 8.54 ± 1.00 
Latency (s) 6.53 ± 1.12 6.21 ± 1.49 
Peripheral ring parameters   
Time (s) 25.27 ± 0.80 27.33 ± 1.35 
   
 
Rats were injected with β-estradiol 3-benzoate (10 µg, s.c.) or vehicle (Control) on the day of 
birth and were tested in the Morris water maze between days 60 and 90 after birth. Parameters 
measured during the probe trial were recorded as storage capacity. Data are means ± S.E.M. of 
values from 9 rats per group (t-test, 
ϯ
 p=0,06 versus the respective control value). 
 
These results demonstrate that during platform training, neonatal estradiol-treated rats 
showed similar learning abilities to those of control animals. Likewise, they did not show 
differences in the storage capacity and in the ability to retain information on the position 
of the platform, acquired during the training. Although numerous evidences have shown 
that allopregnanolone administration impairs spatial memory (Frye and Sturgis 1995; 
Joansson et al. 2002; Matthews et al. 2002), these results, in agreement with the previous 
behavioural data, suggest that the drastic and permanent reduction in the endogenous 
levels of allopregnanolone, induced by neonatal treatment with β-estradiol 3-benzoate, 
does not influence the cognitive behaviour of adult female rats. 
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Effect of neonatal administration of β-estradiol 3-benzoate in the resident-intruder 
test on adult female rats. 
It is well established that gonadal hormones mediate agonistic social interactions. In male 
rodents, castration radically reduces inter-male aggression and the administration of 
testosterone, the main male gonadal hormone, or one of its metabolites, estradiol or 
dihydrotestosterone, restores aggressive behaviours. Furthermore, male mice that cannot 
convert testosterone to estradiol show an estradiol-reversible reduction in aggression 
(Toda et al. 2001). Thus both androgen and estrogens appear to be involved in the 
mediation of aggressive behaviour in males. Moreover, a few studies in males have 
reported that the neurosteroid allopregnanolone is implicated in aggressive behaviour. 
Similar to benzodiazepines, its effect is biphasic, with low doses that increase aggression, 
while high doses are were sedative and likewise reduce aggressive behaviour (Miczek et 
al. 2003). 
There has been much less research conducted on aggression or agonistic behaviour in 
females than male mice. Non reproduction-related agonistic behaviour in females has 
been shown to be qualitatively different from the typical intrasexual aggression studied in 
males, which is less ritualized and more violent (Svare and Gandelman 1973; Al-Maliki 
et al. 1980). In fact, virgin females may use other agonistic behaviours rather than 
attacks, such as chasing, pinning or aggressively grooming the intruder (Grant and 
Mackintosh 1963; Alleva 1993, Clipperton et al. 2008). These behaviours do not lead to 
the violent exclusion of the intruder from the territory, but rather are aimed at establishing 
dominance over the intruder. The study of female agonistic interactions in aggression 
tests therefore requires the use of a comprehensive analysis based on the rat's full 
behavioural repertoire and thus including more than just measures of attacks (Mos and 
Oliver 1989; Olivier et al. 1989; Miczek et al. 2001; Pietropaolo et al. 2004; Branchi et 
al. 2006).  
In the present study, we used the resident-intruder test to investigate the effects of 
neonatal treatment with β-estradiol 3-benzoate on the response of adult female rats to an 
unfamiliar, gonadectomized conspecific intruder (Koolhaas et al. 1980). Neonatal 
administration of β-estradiol 3-benzoate did not affect the non-social behaviours of adult 
female rats. In fact, horizontal and vertical exploration, digging, solitary inactivity and 
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self-grooming were not altered (data not shown). In contrast, neonatal β-estradiol 3-
benzoate treatment increased the dominance score (total agonistic behaviours delivered 
minus total agonistic behaviours received) with respect to control animals (duration: 
+197% p<0.01; frequency: +1235% p<0,05, Figure 6a). 
         (a)  
 
 
 
 
 
 
 
 
         (b)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Effect of neonatal administration of β-estradiol 3-benzoate on the behaviour of adult 
rats in the resident-intruder paradigm. Rats were injected with β-estradiol 3-benzoate (10 µg, 
s.c.) or vehicle (Control) on the day of birth and were tested in the resident-intruder paradigm for 
10 min between days 60 and 90 after birth. Behaviours were analyzed from the time the intruder 
was introduced into the home cage. The duration and frequency of each behaviour were measured 
as: (a) duration and frequency of dominance score. (b) duration and frequency of agonistic 
behaviours delivered. Data are means ± S.E.M. from 20 rats per group. *p<0.01; **p<0.005 
versus the respective control value (t-test). 
 
In fact, agonistic behaviours delivered (follow the intruder, dominant behaviours and 
attacks) increased (duration: +111% p<0,05; frequency: +98% p<0,005; Figure 6b) in 
adult female rats treated with β-estradiol 3-benzoate on the day of birth. In particular, 
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there was an effect of treatment on dominant behaviours (frequency: +131% p<0.05, 
Figure 7; duration: +152% p<0.05, Table 4) and on following the intruder (frequency:  
 
Table 4. Effect of neonatal administration of β-estradiol 3-benzoate on the behaviour of adult 
rats in the resident-intruder paradigm. 
 
Behaviours  Control β-Estradiolo 3- benzoato p 
    
Agonistic behaviours received    
Avoidance    
     Duration (s) 3.56 ± 1.14 3.74 ± 0.89 0,90 
     Frequency (n) 1,81 ± 0.59 2.00 ± 0.48 0,80 
Submissive     
     Duration (s) 42.00 ± 12.99 17,58 ± 5.52 0,08 
     Frequency (n) 4,63 ± 1.44 3,37 ± 0.99 0,47 
Defensive posture     
     Duration (s) 2,19 ± 0.73 2,84 ± 0.63 0,50 
     Frequency (n) 1,50 ± 0.55 2,11 ± 0.39 0,36 
    
Agonistic behaviours delivered    
Follow intruder    
     Duration (s) 3,38 ± 0.74 5,79 ± 0.98 0,07 
Dominant behaviours    
     Duration (s) 14,56 ± 5.29 36,63 ± 8.15 0,04 
Attacks delivered    
     Frequency (n) 0.00 ± 0.00 0,16 ± 0.12 0,22 
    
Social investigation    
Oronasal investigation    
     Duration (s) 23,81 ± 5.63 21,26 ± 2.94 0,68 
     Frequency (n) 10,31 ± 1,57 9,11 ± 1,13 0,53 
Body investigation     
     Duration (s) 84,94 ± 11.04 84,84 ± 8.24 0,99 
     Frequency (n) 27,12 ± 2,49 30,84 ± 2,25 0,28 
Approach/Attend    
     Duration (s) 1.50 ± 0.52 2.11 ± 0.72 0,51 
     Frequency (n) 1.81 ± 0.59 2.32 ± 0.52 0,53 
 
Rats were injected with β-estradiol 3-benzoate (10 µg, s.c.) or vehicle (Control) on the day of 
birth and were tested in the resident-intruder paradigm for 10 min between days 60 and 90 after 
birth. Behaviours were analyzed from the time the intruder was introduced into the home cage. 
The duration and frequency of each behaviour were measured. Data are means ± S.E.M. from 20 
rats per group (t-test).  
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+77% p<0.05, Figure 7), while attacks were not statistically different between groups 
(Table 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Effect of neonatal administration of β-estradiol 3-benzoate on the behaviour of adult 
rats in the resident-intruder paradigm. Rats were injected with β-estradiol 3-benzoate (10 µg, 
s.c.) or vehicle (Control) on the day of birth and were tested in the resident-intruder paradigm for 
10 min between days 60 and 90 after birth. Behaviours were analyzed from the time the intruder 
was introduced into the home cage. The duration and frequency of each behaviour were measured 
as: frequency of dominant behaviours and of following the intruder. Data are means ± S.E.M. 
from 20 rats per group. *p<0.01; **p<0.005 versus the respective control value (t-test). 
 
Therefore these results show that adult female rats, treated on the day of birth with 
estradiol, showed a dominant, but not aggressive, behaviour towards a conspecific 
intruder. Furthermore, neonatal estradiol-treated rats showed an increase in social 
investigation (oronasal investigation, body investigation, anogenital investigation, 
stretched approaches) (frequency: +29% p<0.05, Figure 8a). In particular, there was an 
effect of treatment on the anogenital investigation (duration: +132% p<0.0005; 
frequency: +100% p<0.0005; Figure 8b), with no significant effects on the other 
behaviours (Table 4). 
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          (a) 
 
 
 
 
 
 
 
 
 
           
         (b)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Effect of neonatal administration of β-estradiol 3-benzoate on the behaviour of adult 
rats in the resident-intruder paradigm. Rats were injected with β-estradiol 3-benzoate (10 µg, 
s.c.) or vehicle (Control) on the day of birth and were tested in the resident-intruder paradigm for 
10 min between days 60 and 90 after birth. Behaviours were analyzed from the time the intruder 
was introduced into the home cage. The duration and frequency of each behaviour were measured 
as: (a) frequency of social investigation (b) duration and frequency of anogenitale investigation. 
Data are means ± S.E.M. from 20 rats per group. *p<0.05; **p<0.0005 versus the respective 
control value (t-test). 
 
 
The increase in anogenital investigation observed in neonatal β-estradiol 3-benzoate-
treated rats could be an index of sexual interest toward an intruder of the same sex. This 
behaviour could be attributed to the evidence that neonatal estradiol treatment induces a 
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masculinization of the brain as well as of sexual behaviour (Foecking et al. 2008). In fact, 
anogenital investigation is a typically male appetitive behaviour that serves to establish, 
maintain and promote sexual interaction. Accordingly, we also observed that neonatal β-
estradiol 3-benzoate-treated rats showed numerous mounts with pelvic movements 
similar to the male intromission. It is known that females implemented this male-like 
behaviour for fun, but neonatal β-estradiol 3-benzoate-treated rats showed this behaviour 
in a persistent way. These results are in agreement with the evidence that pre- and post-
natal treatment of female rats with testosterone showed a greater increase in the 
expression of male-like sexual behaviour (Pollak and Sachs 1975; Ward 1969). Moreover, 
females that in utero develop between two males show more male-like sexual behaviour 
during adulthood, compared to females located between two females, and this effect is 
blocked by prenatal treatment with an anti-androgen (Clemens et al. 1978). Therefore, 
these results further support the notion that treatment of females with exogenous estradiol 
or testosterone during development results in masculinization of adult brain and 
behaviour. 
It has been shown that positive allosteric modulators of the GABAA receptor, such as 
allopregnanolone, can affect aggressive behaviour in a dose-dependent manner; high 
doses of these compounds diminish aggressiveness and induce sedation while moderate 
doses may increase aggressiveness (Miczek et al. 2003). Moreover, in the resident 
intruder test, female mice treated with progesterone show a lower aggressive behaviour 
towards the intruder, compared to animals treated with vehicle (Frye et al. 2006). This 
effect appears to be mediated by allopregnanolone, since knockout mice for the 5α-
reductase enzyme (the enzyme responsible for the conversion of progesterone into 
allopregnanolone) treated with progesterone or vehicle, show a similar aggressive 
behaviour towards the intruder, an event associated with the low levels of 
allopregnanolone present in these mice (Frye et al. 2006). The evidence that treatment of 
female rats with β-estradiol 3-benzoate on the day of birth induces a marked reduction in 
the brain and plasma levels of progesterone and allopregnanolone (Chapter 1), suggests 
that this steroids may play a role in the increased agonistic behaviour shown by β-
estradiol 3-benzoate-treated rats.  
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Chapter 3 
 
Neonatal exposure to β-estradiol 3-benzoate enhances the pharmacological effects of 
diazepam in adult female rats. 
 
3.1 Introduction 
 
GABA type A (GABAA) receptors with glycine receptors mediate fast inhibitory 
neurotransmission in the vertebrate CNS by gating Cl
-
 ions through an integral membrane 
channel. GABAA receptors consist of five subunits surrounding a central channel 
selective for chloride ions in the plasma membrane, with the precise subunit composition 
determining the physiological and pharmacological properties of each receptor subtype 
(Olsen and Sieghart 2009). GABAA receptors manifest a high level of structural 
heterogeneity, much greater than that of any other ligand-gated ion channel, with the five 
subunits belonging to various classes (α1 to α6, β1 to β4, γ1 to γ3, δ, ε,  π, θ, ρ1 to ρ3). This 
variety of subunits, each with a specific pattern of expression within the brain, suggests 
the existence of many subtypes of GABAA receptor, each with different potential 
functions and sensitivities to various drugs.  
Several different compounds act on the GABAA receptor, e.g. agonists/antagonists for the 
GABA binding site and allosteric modulators such as benzodiazepines. For instance, 
diazepam is clinically used for its anxiolytic, sedative, hypnotic, anticonvulsant, and 
myorelaxant actions. Several studies have examined the contribution of the different 
GABAA receptor subunits to the effects of benzodiazepines. Transgenic mouse-lines with 
mutations, postulated to alter individual amino acid residues in the benzodiazepine 
binding site, have revealed that receptors composed of α1, α2, α3 or α5 subunits together 
with a β and γ subunit are sensitive to benzodiazepines, are located predominantly at 
synapses, and mediate most phasic inhibition in the brain. By contrast, most receptors 
composed of α4 or α6 subunits together with a β and δ subunit are insensitive to 
benzodiazepines, are located extrasynaptically, and mediate tonic inhibition. Moreover, 
the differential pharmacology of diazepam is largely determined by variations in the 
expression of specific α subunits (Mohler et al. 2006). For example, neurons expressing 
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1 GABAA receptors have been found to mediate the sedative, amnesic and, at least in 
part, the anticonvulsant effects of diazepam, whereas those expressing 2 GABAA 
receptors mediate anxiolysis (Mohler et al. 2006).  
Long-term administration of sedative-hypnotic, anxiolytic, or anticonvulsant drugs or of 
certain drugs of abuse results in marked changes in the expression of specific GABAA 
receptor subunits that lead to the assembly of receptors with different subunit 
compositions and, consequently, different drug sensitivities. Neuroactive steroids that are 
active at GABAA receptors also affect GABAA receptor gene expression and activity in 
various regions of the brain in rats (Concas et al. 1998; Biggio et al. 2007; Maguire and 
Mody 2007; Smith et al. 2007). In particular, the progesterone metabolite 
allopregnanolone induces pharmacological effects similar to those elicited by classical 
positive allosteric modulators such as benzodiazepines (Majewska 1992). Given that 
allopregnanolone is produced, both in the periphery and in the brain, from endogenous 
progesterone (Mellon and Griffin 2002), physiological or pharmacologically induced 
fluctuations in the concentrations of this gonadal steroid are paralleled by changes in the 
synaptic concentration of allopregnanolone, which contribute to the regulation of GABAA 
receptor plasticity. As GABAA receptors are implicated in a variety of 
neuropsychophysiologic phenomena, including anxiety, sleep, seizures, and depression, 
such fluctuations in the concentrations of neuroactive steroids may contribute to the 
cognitive and psychiatric manifestations of conditions characterized by marked changes 
in the hormonal milieu. Pregnancy, delivery, the estrous cycle, and inhibition of gonadal 
function are thus all associated with pronounced changes in the expression of specific 
GABAA receptor subunits in various regions of the brain and with consequent changes in 
receptor function (Concas et al. 1998; Follesa et al. 1998; Griffiths and Lovick 2005; 
Maguire and Mody 2007, 2008; Sanna et al. 2009). 
We have recently demonstrated that neonatal administration of β-estradiol 3-benzoate 
induced changes in the expression of specific GABAA receptor subunits in the cerebral 
cortex of adult female rats (Calza et al. 2010). In particular, immunoblot analysis 
revealed increases in the abundance of 1, 2, and 2 subunits, whereas the amounts of 
3, 4, 5, and  subunits were not affected (Calza et al. 2010). 
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Given that the presence of an  subunit, a  subunit, together with the 2 subunit is 
required for sensitivity of GABAA receptors to benzodiazepines (Pritchett et al. 1989), 
these molecular changes might be expected to affect the pharmacology of GABAA 
receptor–mediated neurotransmission. 
Therefore, we investigated whether the behavioural effects of diazepam in adulthood 
might be affected by neonatal administration of β-estradiol 3-benzoate. 
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3.2 Materials and methods 
 
Animals 
Animal care and handling throughout the experimental procedures and neonatal treatment 
with β-estradiol 3-benzoate were performed as described in chapter 1. The animals were 
subjected to behavioural tests between days 60 and 90 after birth. To avoid effects of 
estrous cycle status, control animals were tested in randomized phases of the estrous 
cycle.  
 
Drug treatment 
Diazepam was dissolved with one drop of Tween 80 in distilled water and was injected 
intraperitoneally (i.p.) at a dose of 0.5, 1, 2 or 6 mg per kilogram of body weight in a 
volume of 3 ml/kg. Control animals received the same volume of vehicle. 
Pentylentetrazole (PTZ) was dissolved and administered as described in chapter 2.  
 
Elevated plus-maze test 
The plus-maze was conducted as described in the materials and methods section of 
chapter 2. Rats were tested in a randomized order between 09.00 and 14.00 hours 
beginning 30 min after the administration of diazepam.  
 
Locomotor activity test 
Locomotor activity of rats was assessed as described in chapter 2. Locomotor activity 
was recorded during the light cycle, between 09.00 and 14.00 hours beginning 15 min 
after the administration of diazepam .  
 
PTZ-induced seizures  
The anticonvulsant activity of diazepam (1 to 6 mg/kg) was tested against PTZ-induced 
seizures (Depoortere et al. 1986), as described in chapter 2. Diazepam was administered 
intraperitoneally 30 min before PTZ.  
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Morris water maze  
Spatial learning was determined by the Morris water maze test as described in chapter 2. 
To assess the amnesic effect of diazepam, rats were injected with diazepam (2 mg/kg, 
i.p.) or vehicle over four consecutive days, 20 minutes before the each training trial 
(Savić et.al. 2009). A drug-free probe trial (McNamara  Skelton 1993) was chosen 
because diazepam impairs acquisition, but not retrieval of escape platform in the water 
maze (Anand et al. 2007; McNamara  Skelton 1991). 
 
Statistical analysis 
Data are presented as means ± S.E.M. The statistical significance of differences was 
assessed by one- or two-way ANOVA and repeated-measure ANOVA with post hoc 
analysis by Newman-Keuls test. A P value of <0.05 was considered statistically 
significant. 
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3.3 Results and discussion  
 
Effect of neonatal administration of β-estradiol 3-benzoate on the anxiolytic and 
sedative actions of diazepam in adult female rats.  
As previously described (Chapter 2), neonatal administration of β-estradiol 3-benzoate 
did not affect the behaviour of adult female rats in the elevated plus-maze test. In 
contrast, neonatal administration of β-estradiol 3-benzoate increased the sensitivity of rats 
to the effects of diazepam in this test (Figure 1).  
 
   Elevated Plus Maze 
 
 
 
 
 
 
 
 
 
Figure 1. Effect of neonatal administration of β-estradiol 3-benzoate on the anxiolytic-like action 
of diazepam in female rats subjected to the elevated plus-maze test. Rats were injected with β-
estradiol 3-benzoate (10 µg, s.c.) or vehicle (Control) on the day of birth and were subjected to 
the elevated plus-maze test for 5 minutes between days 60 and 90 after birth. Diazepam (0.5 to 2 
mg/kg) or vehicle were administered i.p., 30 minutes before the test. The time spent in the open 
arms and the number of entries into the open arms of the maze are expressed as a percentage of 
the corresponding value for control animals and are means ± S.E.M. of values from 10 rats per 
group (Two-way ANOVA followed by Newman-Keuls test). 
 
Consistent with previous observations (Bitran et al. 1991), diazepam (0.5 to 2 mg/kg, i.p.) 
induced an anxiolytic-like action in control rats subjected to the elevated plus-maze test. 
This anxiolytic effect was more pronounced in rats that had been neonatally treated with 
β-estradiol 3-benzoate. The percent increase in the time spent in the open arms and in the 
number of entries into the open arms, following diazepam administration, were thus 
greater in β-estradiol 3-benzoate–treated rats than in control animals (at the diazepam 
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dose of 2 mg/kg: open-arm time, +675 versus +139%, respectively, p<0.001; open-arm 
entries, +256% versus 134%, respectively, p<0.01).  
Moreover, administration of diazepam (6 mg/kg, i.p.) resulted in a significant decrease in 
the total distance travelled and in the number of movements relative to those apparent for 
vehicle-treated animals in both control and β-estradiol 3-benzoate–treated rats (Figure 2). 
However, in rats neonatally treated with β-estradiol 3-benzoate, diazepam induced a more 
pronounced effect on the total distance travelled compared to controls (-99% vs -70%; 
respectively, p<0.05) and on the number of movements (-96% vs -64%, respectively, 
p<0.05). As previously shown (Chapter 2), neonatal administration of β-estradiol 3-
benzoate did not affect the total distance travelled and the total number of movements of 
adult female rats.  
These results clearly demonstrate that diazepam induced a more pronounced anxiolytic-
like effect in the elevated plus-maze test and a greater reduction in locomotor activity in 
rats subjected to neonatal administration of -estradiol 3-benzoate compared to the 
vehicle-treated controls. A similar increased sensitivity to the anxiolytic effect of 
diazepam was previously observed in female rats subjected to neonatal androgen 
treatment (Fernandez-Guasti and Picazo 1997).  
Given that the sedative effect of benzodiazepines requires the 1 subunit of the GABAA 
receptor (Rudolph et al. 1999) whereas the 2 subunit appears to be a major determinant 
of the anxiolytic effect of these drugs (Low et al. 2000), the enhancement of the 
locomotion-suppressing and anxiolytic effects of diazepam observed in rats subjected to 
neonatal administration of -estradiol 3-benzoate may be attributable to the increased 
expression of the 1 and 2 subunits, respectively, in the cerebral cortex.  
Expression of the 2 subunit also appears to be a determinant of the action of 
benzodiazepines at GABAA receptors, given that the binding site for these compounds is 
located at the interface between  and 2 subunits (Olsen and Sieghart 2009). Diazepam 
thus fails to induce sedation or loss of the righting reflex in mice with targeted disruption 
of the 2 subunit gene (Gunther et al. 1995). In addition, transgenic mice that express 
reduced levels of the 2 subunit exhibit enhanced anxiety-like behaviour in the elevated 
plus-maze and forced novel exploratory tests (Crestani et al. 1999). Our observations thus 
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suggest that the increased expression of 1, 2, and 2 subunits in the brain of adult 
female rats subjected to neonatal administration of -estradiol 3-benzoate results in an 
increased assembly of GABAA receptors, containing these specific subunits, which 
therefore exhibit an increased sensitivity to benzodiazepines. 
This greater sensitivity to the anxiolytic effect of diazepam in rats subjected to neonatal 
administration of -estradiol 3-benzoate does not seem to be in relation with the 3 
subunit. In fact, immunoblot analysis revealed that neonatal exposure to β-estradiol 3-
benzoate did not affect the cerebrocortical abundance of this subunit of the GABAA 
receptors (Calza et al. 2010). Indeed, our result is in agreement with experimental 
evidence from the literature showing that GABAA receptors containing the 3 subunit 
mediate only in part the anxiolytic effect of diazepam (Löw et al. 2000; Crestani et al. 
2
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. 
 
 
 
 
 
 
 
 
 
 
Figure 2. Effect of neonatal administration of β-estradiol 3-benzoate on locomotor activity in 
female rats subjected to the motility meter test. Rats were injected with β-estradiol 3-benzoate (10 
µg, s.c.) or vehicle (Control) on the day of birth and were tested for spontaneous locomotor 
activity for 10 min between days 60 and 90 after birth. Diazepam (6 mg/kg, i.p.) or vehicle was 
administered 15 min before the test. The number of movements and the total distance travelled 
were determined. Data are means ± S.E.M. from 10 rats per group. *p<0.001 versus the 
corresponding vehicle-treated group; #p<0.05 versus control rats injected with diazepam (Two-
way ANOVA followed by Newman-Keuls test). 
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Effect of neonatal administration of β-estradiol 3-benzoate on the amnesic effect of 
diazepam. 
Benzodiazepines have been repeatedly found to impair memory acquisition; in fact, they 
cause anterograde amnesia. Amnesic effects in humans were first recognized by 
anesthesiologists using benzodiazepines as pre-medication (Brandt  Oakes 1965; 
Haslett  Dundee 1968). Amnesia induced by benzodiazepines is also reported in animal 
studies (Hinrichs et al. 1984).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effect of neonatal administration of β-estradiol 3-benzoate on the amnesic action of 
diazepam in female rats subjected to the Morris water maze test. Rats were injected with β-
estradiol 3-benzoate (10 µg, s.c.) or vehicle (Control) on the day of birth and were tested in the 
Morris water maze test between days 60 and 90 after birth. Diazepam (2 mg/kg, i.p.) was 
administered each training day 20 minutes before each trial. The time elapsed (latency) to reach 
to the platform was recorded as an acquisition parameter and is expressed in seconds. Data are 
means ±S.E.M. of 10 animals per group. *p<0.05; **p<0.005 versus the respective control 
value (Two-way repeated measures ANOVA, followed by Newman-Keuls test). 
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We thus evaluated whether there was a different sensitivity to the amnesic effect of 
diazepam, in rats subjected to neonatal administration of -estradiol 3-benzoate. As 
expected, diazepam (2 mg/kg), administered 20 minutes before training over four 
consecutive days, altered the acquisition process as shown by the increased latency to 
find the hidden platform in both control and neonatal β-estradiol 3-benzoate–treated rats 
(Figure 4). However, we did not find any differences between these two groups.  
In the probe trial, performed without any pre-treatment because diazepam impairs 
acquisition but not retrieval of spatial information in the water maze, animals treated with 
diazepam during the training showed a decreased number of entries in the area where the 
platform used to be during training; none of the other parameters was significantly 
modified (Table 1). In contrast, neonatal administration of β-estradiol 3-benzoate 
increased the sensitivity of rats to the amnesic effects of diazepam, as shown by a 
significant increase in the latency to reach the area where the platform used to be during 
training (+444%, p<0.01), the latency to reach the platform (east) quadrant (+182%, 
p<0.01) and the latency to reach the target region (+339%, p<0.01). Moreover, the 
administration of diazepam during training decreased the time spent in the platform (east) 
quadrant (-43%, p<0.05) and in the target region (-67%, p<0.01) as well as the number of 
entries in the area where the platform used to be during training (-81%, p<0.01). 
These results demonstrate that neonatal β-estradiol 3-benzoate-treated rats showed a 
greater sensitivity to the amnesic effects of diazepam, compared to the neonatal vehicle-
treated controls. In fact, upon learning the position of the platform just after diazepam 
administration during the training days, recall of the platform position in the subsequent 
probe test was strongly impaired in neonatal β-estradiol 3-benzoate-treated than in 
vehicle-treated control animals. The difference in anterograde impairment, apparent in the 
Morris water maze test, between β-estradiol 3-benzoate-treated and vehicle-treated 
control animals was not linked to a change in overall locomotor activity induced by 
diazepam at the dose of 2 mg/kg, given that the distance travelled through the whole 
water maze did not significantly differ between the two groups.  
Behavioural studies with subtype selective ligands for benzodiazepine receptors (Savić et 
al. 2005a, b, 2008b) and genetically modified animals (Collinson et al. 2002; Crestani et 
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al. 2002; Rudolph et al. 1999) have indicated that the 1 subunit appears to be involved 
in the molecular mechanisms responsible for the induction of anterograde amnesia by 
diazepam (Rudolph and Mohler 1999). In fact, in mice that do not express a diazepam-
sensitive 1 subunit, the memory-impairing effect of diazepam was strongly reduced. 
Accordingly, our results suggest that the greater diazepam-induced amnesia observed in 
neonatal β-estradiol 3-benzoate-treated rats is mediated by the increase in 1 subunit 
expression found in these animals.  
 
Table 1. Effect of neonatal administration of β-estradiol 3-benzoate (EB) on the behaviour of 
adult female rats in the Morris water maze test: different sensitivity to diazepam. 
 
PROBE TRIAL CO CO+DZ EB EB+DZ 
Whole water maze parameters     
Distance(m) 12.50 ± 0.59 15.11 ± 1.19 13.09 ± 0.64 13.28 ± 0.88 
Platform parameters     
No. of entries 2.62 ± 0.67 0.83 ± 0.17# 2.29 ± 0.18 0.43 ± 0.30** 
Latency(s) 21.17 ± 7.30 31.17 ± 6.20 8.59 ± 1.56# 46.70 ± 8.77** 
Platform quadrant(est) 
parameters     
No. of entries(m) 3.88 ± 0.48 4.67 ± 0.42 4.14 ± 0.34 3.57 ± 0.69 
Time(s) 15.35 ± 2.00 12.68 ± 1.16 21.73 ± 2.46+ 12.41 ± 1.67* 
Latency(s) 5.82 ± 1.10 7.43 ± 1.74 4.96 ± 0.59 13.99 ± 4.02** 
Target region parameters     
Time(s) 7.99 ± 1.40 4.44 ± 1.31 8.54 ± 1.00 2.78 ± 1.33** 
Latency(s) 6.53 ± 1.12 17.25 ± 8.71 6.21 ± 1.49 27.26 ± 7.14** 
Peripheral ring parameters     
Time(s) 25.27 ± 0.80 30.73 ± 5.68 27.33 ± 1.35 33.78 ± 6.07 
 
Data represent probe trial parameters and are means ± S.E.M. of 10 animals per group. CO: 
control; DZ: diazepam. #p<0.01 vs CO; *p<0.05, **p<0.01 vs EB (Two-way ANOVA, followed 
by Newman-Keuls test). 
 
 
Effect of neonatal administration of β-estradiol 3-benzoate on the anticonvulsant 
action of diazepam. 
Diazepam is a conventional antiepileptic drug, being a very active compound against 
seizures induced by convulsant agents impairing the GABAergic neurotransmission, such 
as PTZ, a drug that induces tonic convulsions in rats (Crestani et al. 2001). 
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We thus investigated the anticonvulsant activity of diazepam against PTZ-induced 
seizures in control and in β-estradiol 3-benzoate-treated rats (Figure 3). Injection of 
diazepam (1-6 mg/kg), 30 minutes before administration of PTZ (x mg/kg), decreased the 
percentage of animals showing seizures in a dose-dependent manner in both control and 
neonatal β-estradiol 3-benzoate-treated rats. The same treatment failed to affect the 
latency of convulsions. At the most efficacious doses tested (4 and 6 mg/kg), diazepam 
decreased the number of animals showing convulsions to a similar extent in both control 
and neonatal β-estradiol 3-benzoate-treated rats (Figure 3).  
 
Figure 4. Effect of neonatal administration of β-estradiol 3-benzoate on the behaviour of rats in 
the PTZ-seizures tests. Rats were injected with β-estradiol 3-benzoate (10 µg, s.c.) or vehicle 
(Control) on the day of birth and were tested for PTZ-induced seizures between days 60 and 90 
after birth. Diazepam (1-6 mg/kg, i.p.) or vehicle were administered 30 minutes before PTZ (x 
mg/kg, i.p.). Animals were observed for 30 minutes; the latency to the appearance of seizures and 
the number of rats showing convulsions were recorded. Data are means ± S.E.M. of values from 
8 rats per group. *p<0.05 versus the respective control value (Two-way ANOVA followed by 
Newman-Keuls test). 
 
Therefore, neonatal administration of β-estradiol 3-benzoate did not affect sensitivity to 
the anticonvulsant action of diazepam in adulthood. The evidence that the anticonvulsant 
effect of diazepam is similar in both experimental groups seems not to be related to the 
increased expression of the 1 subunit, observed in neonatal β-estradiol 3-benzoate-
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treated rats. In fact, the anticonvulsant activity of diazepam, assessed by its protection 
against PTZ-induced tonic convulsions, was reduced in mice that do not express a 
diazepam-sensitive 1 subunit (Rudolph and Möhler 2004). The anticonvulsant effect of 
diazepam, which persisted in these mice, was due to GABAA receptors other than 1 
subunit type, since it was antagonized by flumazenil, suggesting that the anticonvulsant 
activity of benzodiazepines is partially but not fully mediated by receptors containing the 
1 subunit (Rudolph and Möhler 2004). Accordingly, the expression of other subunits 
(3, 4, and 5) was not affected by neonatal treatment with β-estradiol 3-benzoate. 
Overall, the results of this study demonstrate that neonatal administration of β-estradiol 
3-benzoate induced an alteration in the behavioural response to diazepam in adulthood. 
Specifically, these animals showed a greater sensitivity to the anxiolytic, sedative and 
amnesic effects of diazepam but not to its anticonvulsant effect. Given that these effects 
of benzodiazepines seem to be mediated by specific GABAA  and  subunits, our 
previous observation that neonatal treatment with β-estradiol 3-benzoate increases the 
expression of 1, 2 and 2 subunits in the cerebral cortex might imply that this 
treatment is capable to increase, in the adult brain, the expression of assembled cortical 
GABAA receptors containing these specific subunits, which exhibit a greater sensitivity 
to benzodiazepines. Moreover, these results further demonstrate that estradiol plays a 
major role in the modulation of GABAergic transmission during development. 
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Summary and Conclusions 
 
 
Circulating steroid hormones synthesized either from peripheral endocrine glands or from 
the brain can directly regulate brain function and modulate behaviour. Gonadal steroid 
hormones, especially during ontogeny, cause many sex differences that are not 
manifested behaviourally until sexual maturity is attained. In summary, we observed that 
the single administration of a very low dose of β-estradiol 3-benzoate on the day of birth 
might represent a useful experimental model to further investigate the physiological role 
of steroid hormones in the modulation of adult behaviour. Thus, female rats treated with 
β-estradiol 3-benzoate showed a delay in vaginal opening, aciclicity characterized by 
prolonged estrus, and ovarian failure. Moreover, this treatment abolished sexual 
receptivity in adulthood, even following estrogen and progesterone replacement after 
ovariectomy. Most importantly, these estrogenized animals showed a disregulation of the 
hypothalamic-pituitary-gonadal axis that triggered a pronounced decrease in the 
cerebrocortical and brain concentrations of progesterone and its neuroactive metabolite 
allopregnanolone, that were apparent in both juvenile and adult animals. In contrast, this 
treatment did not affect 17β-estradiol levels. To our knowledge, this is the first evidence 
that perinatal exposure to estrogen in female rats induced a selective and long lasting 
alteration in the plasma and, most important, in the brain concentrations of progesterone 
and allopregnanolone.  
Although allopregnanolone seems to be involved in the regulation of a variety of 
psychophysiological phenomena, including anxiety, depression, sleep, cognitive function, 
seizures, social and sexual behaviour, the drastic and persistent reduction in the brain and 
peripheral concentrations of this neuroactive steroid failed to affect several behaviours 
measured in adult female rats neonatally treated with β-estradiol 3-benzoate. In fact, this 
treatment did not affect locomotor activity, anxiety- and mood-related behaviours, 
seizures sensitivity and spatial memory. In contrast, neonatal β-estradiol 3-benzoate-
treated rats showed a dominant, but not aggressive, behaviour and an increase in body 
investigation, especially anogenital investigation, characteristic of a male appetitive 
behaviour. Given that the decrease in allopregnanolone concentration induced by 
neonatal β-estradiol 3-benzoate treatment appeared early (3 weeks) in development, it is 
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possible that estrogenized female rats have developed an adaptative mechanism to 
counteract the persistent decrease in brain levels of this neuroactive steroid. Accordingly, 
we have previously shown that neonatal β-estradiol 3-benzoate treatment did not affect 
the anxiolytic-like action of allopregnanolone in the elevated plus-maze (Calza et al. 
2010). Moreover, neonatally androgenized or ovariectomized female rats were previously 
shown to be insensitive to the anxiolytic action of allopregnanolone in the elevated plus-
maze test (Fernandez-Guasti and Picazo 1999; Laconi et al. 2001). The lack of sensitivity 
to the behavioural effect of allopregnanolone might be explained by the failure of β-
estradiol 3-benzoate treatment to affect expression of the 4 and subunits of the 
GABAA receptor (Calza et al. 2010). Moreover, we have found a decrease in the 
expression of  subunit in the hippocampus of neonatal β-estradiol 3-benzoate-treated 
rats (Concas et al. personal communication). Receptors that contain these subunits are 
located at extrasynaptic sites in various brain regions, mediate tonic inhibition of 
neuronal activity, and are highly sensitive to modulation by allopregnanolone but not by 
benzodiazepines (Smith et al. 2007). Ablation of the  subunit influences the behavioural 
profile of neuroactive steroids in mice, with the anxiolytic-like effect in the elevated plus-
maze test induced by allopregnanolone or ganaxolone being reduced in animals lacking 
the  subunit (Mihalek et al. 1999).  
Moreover, neonatal administration of β-estradiol 3-benzoate to female rats increases 
sensitivity to the anxiolytic, sedative, and amnesic effects of diazepam in adulthood. 
Given that these effects seem to be mediated by specific GABAA receptor subunits (α1, 
α2 and γ2), the greater sensitivity of neonatally β-estradiol 3-benzoate-treated females to 
diazepam could be related to the changes in the expression of these subunits observed in 
the brain of these animals (Calza et al. 2010). Furthermore, the evidence that neonatal 
administration of β-estradiol 3-benzoate did not modify the sensitivity to the 
anticonvulsant action of diazepam indicates that this treatment does not alter the rate of 
diazepam metabolism. Given that the α1 subunit only partially mediates the 
anticonvulsant effect of benzodiazepines, other mechanisms may underlie the sensitivity 
of neonatal β-estradiol 3-benzoate-treated rats to the anticonvulsant effect of diazepam.  
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Overall, these results indicate that the marked and persistent reduction in the 
cerebrocortical and peripheral concentration of the neuroactive steroid allopregnanolone 
induced by neonatal treatment with β-estradiol 3-benzoate does not change baseline 
behaviours in adult rats. On the contrary, the low levels of allopregnanolone seems to be 
associated to changes in the behavioural sensitivity to the positive allosteric modulator of 
the GABAA receptor, diazepam. The differences in the behavioural efficacy of diazepam 
may be due to the increased expression of specific GABAA receptor subunits, induced by 
neonatal β-estradiol 3-benzoate treatment, which therefore, may lead to the formation of 
receptor’ subtypes that show a greater sensitivity to diazepam. Given that 
allopregnanolone exposure alters GABAA receptor subunit expression, the changes in 
allopregnanolone concentrations induced by neonatal β-estradiol 3-benzoate treatment 
might have implications for the structure and function of GABAA receptors during 
development. Indeed, perinatal administration of allopregnanolone was found to 
participate in the normal development of GABAergic neurotransmission by altering the 
GABAA receptor-mediated Cl
-
 influx (Grobin and Morrow, 2001) and by influencing the 
localization of GABAergic interneurons in the prefrontal cortex of adult rats (Grobin et 
al. 2003). Allopregnanolone levels in the cerebral cortex of rats have previously been 
shown to undergo dynamic changes during development, with maximal concentrations 
apparent around the second postnatal week (Grobin and Morrow 2001). In the present 
study, we found that neonatal administration of -estradiol 3-benzoate induced a marked 
decrease in allopregnanolone concentrations in the cerebral cortex of rats at 21 days of 
age. Such treatment might thus prevent the surge in allopregnanolone levels during the 
first weeks of life and thereby affect the developmental plasticity of GABAA receptors 
and consequently the pharmacology of these receptors.  
In conclusion, female rats neonatally treated with β-estradiol 3-benzoate may represent a 
potential animal model in which to study the effects of estrogen on reproductive function 
and on the reproductive neuroendocrine system, and to examine the role of gonadal 
steroids in behaviour. These results further demonstrate that estradiol plays an important 
role in the modulation of GABAergic transmission during development of the central 
nervous system.  
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Moreover, this animal model could be useful to study one of the most common endocrine 
disorders in women such as the polycystic ovary syndrome (PCOS). Evidence from both 
clinical and animal studies suggests that PCOS has a developmental origin, in which 
androgen excess during fetal or prepubertal life can reprogram multiple tissues to 
manifest the syndrome in adolescence and adulthood (Abbott et al. 2005; Xita and 
Tsatsoulis 2006). This disorder is often accompanied by anovulation, amenorrhea and 
polycystic ovaries of infertility in women. In female rats, neonatal estrogenization 
induces some of these characteristics, such as poly-follicular ovarian histology, ovarian 
failure and a lack of estrous cyclicity.  
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